{"protocolSection": {"identificationModule": {"nctId": "NCT01626079", "orgStudyIdInfo": {"id": "11-512"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS", "officialTitle": "A Clinical Evaluation of the Safety and Effectiveness of the MitraClip\u00ae System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)", "acronym": "COAPT"}, "statusModule": {"statusVerifiedDate": "2023-11", "overallStatus": "ACTIVE_NOT_RECRUITING", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-08", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2024-07", "type": "ESTIMATED"}, "studyFirstSubmitDate": "2012-06-20", "studyFirstSubmitQcDate": "2012-06-21", "studyFirstPostDateStruct": {"date": "2012-06-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-07-30", "resultsFirstSubmitQcDate": "2020-04-26", "resultsFirstPostDateStruct": {"date": "2020-05-06", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-11-22", "lastUpdatePostDateStruct": {"date": "2023-11-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) Trial is to confirm the safety and effectiveness of the MitraClip System for the treatment of moderate-to-severe or severe functional mitral regurgitation (FMR) in Symptomatic Heart Failure Subjects who are treated per standard of care and who have been determined by the site's local heart team as not appropriate for mitral valve surgery. This randomized controlled trial will provide the opportunity to strengthen or add labeling claims regarding safety and clinical benefits of the MitraClip System for symptomatic heart failure patients with moderate-to-severe or severe functional mitral regurgitation.\n\nApproximately 610 subjects will be randomized at up to 100 investigational sites with approximately 305 subjects targeted to receive the study device. COAPT study completed recruiting subjects in June 2017.\n\nAs part of the COAPT trial, a subset of patients will be registered in the cardiopulmonary exercise (CPX) sub-study. The objective of this sub-study is to evaluate the exercise responses in a sub-cohort of COAPT subjects who receive MitraClip device (Device group) compared to the Control group who do not receive MitraClip device. (Note: the CPX Sub-study subjects will contribute to the analyses of the COAPT primary and secondary endpoints)\n\nAs an extension of the COAPT RCT trial, COAPT CAS study will be conducted after COAPT enrollment is complete under the same investigational device exemption (IDE(G120024)). The objective of this study is to evaluate the MitraClip\u00ae NT System for the treatment of clinically significant functional mitral regurgitation (FMR) in symptomatic heart failure subjects who are treated per standard of care and who have been determined by the site's local heart team as not appropriate for mitral valve surgery. The anticipated Study Completion Date is July 2024. COAPT CAS completed recruiting subjects in March 2019.", "detailedDescription": "Prospective, randomized, parallel-controlled, multicenter clinical evaluation of the MitraClip device for the treatment of clinically significant functional mitral regurgitation in symptomatic heart failure subjects who are treated per standard of care and who have been determined by the site's local heart team as not appropriate for mitral valve surgery. Eligible subjects will be randomized in a 1:1 ratio to the MitraClip device (Device group) or to no MitraClip device (Control group).\n\nAs part of the COAPT trial, a subset of patients (at least 50 up to 100 in total) will be registered in the CPX Sub-study, which is designed as a prospective, randomized (1:1 ratio to the MitraClip or no MitraClip device), parallel-controlled, multicenter study registering approximately 50-100 subjects in up to 50 qualified US sites from the COAPT trial. Subjects registered and randomized in the CPX Sub-study will contribute to the total enrollment approximately of 610 subjects in the COAPT trial. Roll-in subjects will not participate in the CPX Sub-study.\n\nThe COAPT CAS study is designed as a prospective, multicenter, single arm, continued access registry study. A maximum of 800 subjects (anticipated) will be registered from up to 75 sites in the United States. The enrollment will end once pre-market approval (PMA) of the proposed expanded indication of MitraClip System is obtained. Active follow-up of patients will be performed through 12 months with scheduled visits at 30 days and 12 months. The national Trans catheter Valve Therapy Registry (TVT Registry) will be used for data collection through 12 months. Annual follow-up data from 2 years through year 5 post-implant will be obtained by linkage to the Centers for Medicare and Medicaid Services (CMS) Claims database.\n\nCOAPT CAS data may be used to support the PMA application of the labeling claims for the treatment of moderate to severe or severe FMR in symptomatic heart failure subjects. This single arm registry will provide valuable new information regarding use of the MitraClip\u00ae NT System under more \"real world\" conditions.\n\nCOAPT study completed recruiting subjects in June 2017. COAPT CAS completed recruiting subjects in March 2019. A total of 162 subjects were enrolled in the COAPT CAS Group."}, "conditionsModule": {"conditions": ["Mitral Regurgitation", "Mitral Valve Regurgitation", "Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects", "Heart Failure"], "keywords": ["Functional Mitral Regurgitation", "Mitral Valve Regurgitation", "Symptomatic Heart Failure", "Functional MR", "MitraClip", "Mitral Valve Insufficiency", "Cardiopulmonary exercise testing", "COAPT CAS", "COAPT Continued Access Study", "MitraClip NT"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE", "maskingDescription": "614 in the Randomized Group for COAPT Trial and 162 Subjects in the COAPT CAS Group"}}, "enrollmentInfo": {"count": 776, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "MitraClip System", "type": "EXPERIMENTAL", "description": "Percutaneous mitral valve repair using MitraClip System", "interventionNames": ["Device: MitraClip System"]}, {"label": "Control Group", "type": "NO_INTERVENTION", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}, {"label": "COAPT CAS Group", "type": "EXPERIMENTAL", "description": "Percutaneous mitral valve repair using MitraClip System", "interventionNames": ["Device: MitraClip System"]}], "interventions": [{"type": "DEVICE", "name": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System", "armGroupLabels": ["COAPT CAS Group", "MitraClip System"], "otherNames": ["MitraClip device", "MitraClip"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Primary Safety Endpoint - Percentage of Participants With Freedom From Device Related Complications at 12 Months", "description": "Percentage of Participants with Freedom from Device related Complications at 12 Months.\n\nComposite of Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, and any device related complications requiring non-elective cardiovascular surgery.", "timeFrame": "12 months"}, {"measure": "Primary Effectiveness Endpoint", "description": "Recurrent HF hospitalizations (HFH) through 24 months, analyzed when the last subject completes 12-month follow-up", "timeFrame": "24 months"}], "secondaryOutcomes": [{"measure": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "description": "Number of recurrent Heart Failure hospitalization events at 12 months.", "timeFrame": "12 months"}, {"measure": "New York Heart Association (NYHA) Functional Class (COAPT CAS Study Analysis)", "description": "The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I - No symptoms and no limitation in ordinary physical activity Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class III - Marked limitation in activity due to symptoms Class IV - Severe limitations.", "timeFrame": "12 months"}, {"measure": "New York Heart Association (NYHA) Functional Class (COAPT CAS Study Analysis)", "description": "The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I - No symptoms and no limitation in ordinary physical activity Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class III - Marked limitation in activity due to symptoms Class IV - Severe limitations.", "timeFrame": "30 days"}, {"measure": "Quality of Life (QOL) (COAPT CAS Study Analysis) Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self administered instrument that quantifies physicalfunction, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possiblesubscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies thefollowing six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical FunctionDomain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQSymptom Stability Domain, Clinical Summary Score and Overall Summary Score. Clinical Summary Scoreincludes total symptom and physical function scores to correspond with NYHA Classification. Overall SummaryScore includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "12 months"}, {"measure": "Quality of Life (QOL) (COAPT CAS Study Analysis) Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score. Clinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification. Overall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "30 days"}, {"measure": "Six Minute Walk Test (6MWT Distance or 6MWD) (COAPT CAS Study Analysis)", "description": "The Six Minute Walk Test (6MWT) is a practical simple test that requires a 100-ft hallway but no exerciseequipment or advanced training for technicians. This test measures the distance that a patient can quickly walk ona flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of allthe systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation,peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific informationon the function of each of the different organs and systems involved in exercise or the mechanism of exerciselimitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses thesubmaximal level of functional capacity.", "timeFrame": "12 months"}, {"measure": "Six Minute Walk Test (6MWT Distance or 6MWD) (COAPT CAS Study Analysis)", "description": "The Six Minute Walk Test (6MWT) is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific information on the function of each of the different organs and systems involved in exercise or the mechanism of exercise limitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses the submaximal level of functional capacity.", "timeFrame": "30 days"}, {"measure": "Mitral Regurgitation (MR) Severity (COAPT CAS Study Analysis)", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "12 months"}, {"measure": "Mitral Regurgitation (MR) Severity (COAPT CAS Study Analysis)", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "30 days"}, {"measure": "Major and/or Life Threatening Bleeding (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Major and/or Life Threatening Bleeding (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Major Vascular Complications (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Major Vascular Complications (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Renal Complication With Requirement for Dialysis (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Renal Complication With Requirement for Dialysis (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Transient Ischemic Attack (TIA) (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Transient Ischemic Attack (TIA) (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "timeFrame": "12 months"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "timeFrame": "30 days"}, {"measure": "Percentage of Patients Free From the Composite of All-cause Death, Stroke, MI, or Non-elective Cardiovascular Surgery for Device Related Complications in the Device Group", "description": "The percentage of patients free from the composite endpoint as described above.", "timeFrame": "30 days post-procedure in the Device group"}, {"measure": "Number of Deaths at 12 Months (All Cause Mortality)", "description": "Death from any cause mortality at 12months.", "timeFrame": "12 months"}, {"measure": "Number of Participants With Mitral Regurgitation Severity Grade of 2+ or Lower at 12 Months", "description": "MR severity grade of 2+ or lower at 12 months MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "12 months"}, {"measure": "Change in Distance Walked on the 6 Minute Walk Test (6MWT Distance or 6MWD)", "description": "The 6MWT is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific information on the function of each of the different organs and systems involved in exercise or the mechanism of exercise limitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses the submaximal level of functional capacity.", "timeFrame": "12 months over baseline"}, {"measure": "Change in Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 12 month KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "12 months over baseline"}, {"measure": "Change in Left Ventricular End Diastolic Volume (LVEDV)", "description": "Paired data comparing the Change in LVEDV at baseline vs 12 months", "timeFrame": "12 months over baseline"}, {"measure": "Number of Participants With New York Heart Association (NYHA) Functional Class I/II", "description": "NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA CLASS)\n\nClass I: Patients with cardiac disease but without resulting limitations of physical activity.\n\nClass II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.\n\nClass III: Patients with cardiac disease resulting in marked limitation of physical activity. Patients are comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation dyspnea, or anginal pain.\n\nClass IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or of the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.", "timeFrame": "12 months"}, {"measure": "Recurrent Hospitalizations - All Cause", "description": "Number of Recurrent Hospitalizations for any cause within 24 months.", "timeFrame": "24 Months"}, {"measure": "Death or HF Hospitalization Within 24 Months (Finkelstein-Schoenfeld Analysis of All-Cause Death or Recurrent HF Hospitalization Through 24 Months)", "description": "The win ratio is a useful method for providing an estimate of the treatment effect when composite endpoints are analyzed as the analysis accounts for clinical significance of the outcomes of interest. For example, in the composite of death and recurrent HF hospitalizations through 24 months, subjects in the Device and Control groups were formed into matched pairs, where each pair of subjects was classified into 1 of 5 outcomes scenarios:\n\nA. Death in Device group first B. Death in Control group first C. More HF hospitalizations in the Device group (or in the case of a tie, the first HF hospitalization in the Device group occurs first) D. More HF hospitalization in the Control group (or in the case of tie, the first HF hospitalization in the Control group occurs first) E. None of the above In this way, the number of \"Winners\" in the Device group was NW = NB + ND while the number of \"Losers\" in the Device group was NL = NA + NC. The \"Win Ratio\" was then calculated as NW/NL.", "timeFrame": "24 months"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "description": "The COAPT study is still on-going. Only the Primary and major secondary endpoints have been entered. Rest of the results will be entered when the study ends in July 2024.", "timeFrame": "2 years"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "timeFrame": "3 years"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "timeFrame": "4 years"}, {"measure": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "timeFrame": "5 years"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "2 years"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "3 years"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "4 years"}, {"measure": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "timeFrame": "5 years"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "2 years"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "3 years"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "4 years"}, {"measure": "Stroke (COAPT CAS Study Analysis)", "timeFrame": "5 years"}, {"measure": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "timeFrame": "2 years"}, {"measure": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "timeFrame": "3 years"}, {"measure": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "timeFrame": "4 years"}, {"measure": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Death from any cause within 24 months - no of events", "timeFrame": "24 months"}], "otherOutcomes": [{"measure": "Device or Procedure-Related Adverse Events", "description": "Device or procedure-related adverse events are defined as adverse events that are adjudicated by the Clinical Events Committee as possibly, probably or definitely device and/or procedure-related, regardless of the temporal relationship to the MitraClip procedure. Device or procedure-related adverse events will be broken down into those that occur within 30 days of the procedure and those that occur after 30 days of the procedure. Examples of device-related adverse events are: myocardial perforation, Single Leaflet Device Attachment, embolization of the MitraClip device or MitraClip System components, iatrogenic atrial septal defect, mitral valve stenosis, need for mitral valve replacement instead of repair due at least in part to the MitraClip procedure or the presence of the MitraClip device.", "timeFrame": "Within and after 30 days of the procedure"}, {"measure": "Implant Rate", "description": "Defined as the rate of successful delivery and deployment of the MitraClip device(s) with echocardiographic evidence of leaflet approximation and retrieval of the delivery catheter", "timeFrame": "Day 0"}, {"measure": "Device Procedure Time", "description": "Defined as the time elapsed from the start of the transseptal procedure to the time the Steerable Guide Catheter is removed", "timeFrame": "Day 0"}, {"measure": "Total Procedure Time", "description": "Defined as the time elapsed from the first of any of the following: intravascular catheter placement, anesthesia or sedation, or transesophageal echocardiogram (TEE), to the removal of the last catheter and TEE", "timeFrame": "Day 0"}, {"measure": "Device Time", "description": "Defined as the time the Steerable Guide Catheter is placed in the intra-atrial septum until the time the MitraClip Delivery System (CDS) is retracted into the Steerable Guide Catheter", "timeFrame": "Day 0"}, {"measure": "Fluoroscopy Duration", "description": "Defined as the duration of exposure to fluoroscopy during the MitraClip procedure", "timeFrame": "Day 0"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "Baseline"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "6 months"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "12 months"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "24 months"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "3 years"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ -Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "4 years"}, {"measure": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography andsubjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effectiveregurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Rightventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ -Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitantorifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricularEF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "timeFrame": "5 years"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "Baseline"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "6 months"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "12 months"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "24 months"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "3 years"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "4 years"}, {"measure": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "timeFrame": "5 years"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "Baseline"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "6 months"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "12 months"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "24 months"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from theLeft Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "3 years"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "4 years"}, {"measure": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "timeFrame": "5 years"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "Baseline"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "6 months"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "12 months"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "24 months"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricledue to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "3 years"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "timeFrame": "4 years"}, {"measure": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency", "timeFrame": "5 years"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "Baseline"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "6 months"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "12 months"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "24 months"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "3 years"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "4 years"}, {"measure": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "timeFrame": "5 years"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "Baseline"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "6 months"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "12 months"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "24 months"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction,or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at anypoint in the cardiac cycle.", "timeFrame": "3 years"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "4 years"}, {"measure": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "timeFrame": "5 years"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "Baseline"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "6 months"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "12 months"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "24 months"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "3 years"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "4 years"}, {"measure": "Left Ventricular End Diastolic Dimension (LVEDD)", "timeFrame": "5 years"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "Baseline"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "6 months"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "12 months"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "24 months"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "3 years"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "4 years"}, {"measure": "Left Ventricular End Systolic Dimension (LVESD)", "timeFrame": "5 years"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "Baseline"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "6 months"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "12 months"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "24 months"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "3 years"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "4 years"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "timeFrame": "5 years"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "Baseline"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "6 months"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "12 months"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "24 months"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "3 years"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "4 years"}, {"measure": "Right Ventricular Systolic Pressure (RVSP)", "timeFrame": "5 years"}, {"measure": "Mitral Valve Area", "timeFrame": "Baseline"}, {"measure": "Mitral Valve Area", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Mitral Valve Area", "timeFrame": "6 months"}, {"measure": "Mitral Valve Area", "timeFrame": "12 months"}, {"measure": "Mitral Valve Area", "timeFrame": "24 months"}, {"measure": "Mitral Valve Area", "timeFrame": "3 years"}, {"measure": "Mitral Valve Area", "timeFrame": "4 years"}, {"measure": "Mitral Valve Area", "timeFrame": "5 years"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "Baseline"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "6 months"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "12 months"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "24 months"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, thevalve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valvegradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "3 years"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "4 years"}, {"measure": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "timeFrame": "5 years"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "Baseline"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "6 months"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "12 months"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "24 months"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "3 years"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "4 years"}, {"measure": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "timeFrame": "5 years"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "Baseline"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "6 months"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "12 months"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "24 months"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "3 years"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "4 years"}, {"measure": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "timeFrame": "5 years"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "Baseline"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "6 months"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "12 months"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "24 months"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "3 years"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "4 years"}, {"measure": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "12 months in Device group"}, {"measure": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "24 months in Device group"}, {"measure": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "3 years in Device group"}, {"measure": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device relatedcomplications including Single Leaflet Device Attachment (SLDA), deviceembolizations, endocarditis requiring surgery, Echocardiography Core Laboratoryconfirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at12 months will be the primary measure of safety.", "timeFrame": "4 years in Device group"}, {"measure": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at12 months will be the primary measure of safety.", "timeFrame": "5 years in Device group"}, {"measure": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "24 months in Device group"}, {"measure": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet DeviceAttachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratoryconfirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complicationsrequiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "3 years in Device group"}, {"measure": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "4 years in Device group"}, {"measure": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "timeFrame": "5 years in Device group"}, {"measure": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 24 months", "timeFrame": "24 months"}, {"measure": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 36 months", "timeFrame": "3 years"}, {"measure": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 48 months", "timeFrame": "4 years"}, {"measure": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 60 months", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "timeFrame": "12 months"}, {"measure": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "timeFrame": "24 months"}, {"measure": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "timeFrame": "3 years"}, {"measure": "Kaplan-Meier Freedom From Cardiovascular Mortality", "timeFrame": "4 years"}, {"measure": "Kaplan-Meier Freedom From Cardiovascular Mortality", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "timeFrame": "12 months"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "timeFrame": "24 months"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "timeFrame": "3 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "timeFrame": "4 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "timeFrame": "12 months"}, {"measure": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "timeFrame": "24 months"}, {"measure": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "timeFrame": "3 years"}, {"measure": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "timeFrame": "4 years"}, {"measure": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "timeFrame": "5 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "timeFrame": "12 months"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "description": "Survival rate from the first HF related hospitalization or all-cause mortality.", "timeFrame": "24 months"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "timeFrame": "3 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "timeFrame": "4 years"}, {"measure": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "timeFrame": "5 years"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "timeFrame": "Baseline"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "timeFrame": "30 days"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "timeFrame": "6 months"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "timeFrame": "12 months"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "timeFrame": "24 months"}, {"measure": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifyingthe extent of heart failure. It classifies patients in one of four categories based on their limitations during physicalactivity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness ofbreath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due tosymptoms Class IV: Severe limitations", "timeFrame": "3 years"}, {"measure": "NYHA Functional Class", "timeFrame": "4 years"}, {"measure": "NYHA Functional Class", "timeFrame": "5 years"}, {"measure": "Six-Minute Walk Test Distance (6MWD)", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "timeFrame": "Baseline"}, {"measure": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "timeFrame": "30 days"}, {"measure": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "timeFrame": "6 months"}, {"measure": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "timeFrame": "12 months"}, {"measure": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "timeFrame": "24 months"}, {"measure": "Change in 6MWD From Baseline", "timeFrame": "Between baseline and 30 days"}, {"measure": "Change in 6MWD From Baseline", "timeFrame": "Between baseline and 6 months"}, {"measure": "Change in 6MWD From Baseline", "timeFrame": "Between baseline and 12 months"}, {"measure": "Change in 6MWD From Baseline", "timeFrame": "Between baseline and 24 months"}, {"measure": "Kansas City Cardiomyopathy Questionnaire (KCCQ) QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "Baseline"}, {"measure": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "30 days"}, {"measure": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "6 months"}, {"measure": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "12 months"}, {"measure": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "24 months"}, {"measure": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 30 days KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "Between baseline and 30 days"}, {"measure": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 6 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "Between baseline and 6 months"}, {"measure": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 12 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "Between baseline and 12 months"}, {"measure": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 24 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "timeFrame": "Between baseline and 24 months"}, {"measure": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "Baseline"}, {"measure": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "30 days"}, {"measure": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "6 months"}, {"measure": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "12 months"}, {"measure": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "24 months"}, {"measure": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 30 days SF-36. The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "Between baseline and 30 days"}, {"measure": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 6 months days SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "Between baseline and 6 months"}, {"measure": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 12 month SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "Between baseline and 12 months"}, {"measure": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 24 months SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "timeFrame": "Between baseline and 24 months"}, {"measure": "Mitral Valve Surgery (Including Type of Surgery), New Use of CRT, New Use of Single or Dual Chamber Pacemaker, Permanent LVAD Implant, Heart Transplant, Additional MitraClip Device Intervention in Device Group", "timeFrame": "Through 5 years"}, {"measure": "De Novo MitraClip Device Intervention in Control Group", "timeFrame": "Through 5 years"}, {"measure": "Responder Analysis for 6MWD", "description": "Where responder is defined as alive and experiencing an improvement of 24 meters and 50 meters (difference in proportion of responders between Device and Control groups)", "timeFrame": "12 months"}, {"measure": "Responder Analysis for 6MWD", "description": "Where responder is defined as alive and experiencing an improvement of 24 meters and 50 meters (difference in proportion of responders between Device and Control groups)", "timeFrame": "24 months"}, {"measure": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "timeFrame": "12 months"}, {"measure": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "timeFrame": "24 months"}, {"measure": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "timeFrame": "3 years"}, {"measure": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "timeFrame": "4 years"}, {"measure": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "timeFrame": "5 years"}, {"measure": "Responder Analysis for QoL (KCCQ)", "description": "Where responder is defined as alive and experiencing an improvement of 5 points (difference in proportion of responders between Device and Control groups)", "timeFrame": "12 months"}, {"measure": "Responder Analysis for QoL (KCCQ)", "description": "Where responder is defined as alive and experiencing an improvement of 5 points (difference in proportion of responders between Device and Control groups)", "timeFrame": "24 months"}, {"measure": "Each Subscale for QoL (KCCQ)", "description": "difference in means between Device and Control groups for the Kansas City Cardiomyopathy Questionnaire (KCCQ) for the physical limitation and symptom stability scores.", "timeFrame": "12 months"}, {"measure": "Each Subscale for QoL (KCCQ)", "description": "difference in means between Device and Control groups for the Kansas City Cardiomyopathy Questionnaire (KCCQ) for the physical limitation and symptom stability scores.", "timeFrame": "24 months"}, {"measure": "Length of Index Hospitalization for MitraClip Procedure (Device Group)", "description": "Length of stay in the hospital for the MitraClip Index procedure (device group)", "timeFrame": "Before MitraClip procedure on day 0"}, {"measure": "Number of Hospitalizations and Reason for Hospitalization (i.e. Heart Failure, Cardiovascular, Non-cardiovascular)", "description": "in each of the Device and Control groups", "timeFrame": "12 months"}, {"measure": "Number of Hospitalizations and Reason for Hospitalization (i.e. Heart Failure, Cardiovascular, Non-cardiovascular)", "description": "in each of the Device and Control groups", "timeFrame": "24 months"}, {"measure": "Number of Days Alive and Out of Hospital", "description": "mean no of days alive and out of hospital in both Device and Control groups", "timeFrame": "From the time of randomization to 12 months"}, {"measure": "Number of Days Alive and Out of Hospital", "description": "mean Number of days alive and out of hospital for the Device and Control groups", "timeFrame": "From the time of randomization to 24 months"}, {"measure": "Number of Days Alive and Out of Hospital", "description": "Mean Number of days alive and out of hospital for the Device and Control groups", "timeFrame": "From the time of randomization to 3 Years"}, {"measure": "Number of Days Alive and Out of Hospital", "description": "difference in medians between Device and Control groups", "timeFrame": "From the time of randomization to 4 Years"}, {"measure": "Number of Days Alive and Out of Hospital", "description": "difference in medians between Device and Control groups", "timeFrame": "From the time of randomization to 5 Years"}, {"measure": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "timeFrame": "12 months"}, {"measure": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "timeFrame": "24 months"}, {"measure": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "timeFrame": "3 Years"}, {"measure": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "difference in medians between Device and Control groups", "timeFrame": "4 Years"}, {"measure": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "difference in medians between Device and Control groups", "timeFrame": "5 Years"}, {"measure": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "timeFrame": "12 months"}, {"measure": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "timeFrame": "24 months"}, {"measure": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "timeFrame": "3 years"}, {"measure": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "timeFrame": "4 years"}, {"measure": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "timeFrame": "5 years"}, {"measure": "Proportion of Subjects Living in the Baseline Location", "description": "Subjects living in the baseline location include : home, retirement home, nursing facility and other location.", "timeFrame": "12 months"}, {"measure": "Proportion of Subjects Living in the Baseline Location", "description": "Subjects living in the baseline location include : home, retirement home, nursing facility and other location.", "timeFrame": "24 months"}, {"measure": "Proportion of Subjects Living in the Baseline Location", "timeFrame": "3 years"}, {"measure": "Proportion of Subjects Living in the Baseline Location", "timeFrame": "4 years"}, {"measure": "Proportion of Subjects Living in the Baseline Location", "timeFrame": "5 years"}, {"measure": "Mitral Valve Replacement Rates", "description": "Subjects with mitral valve replacements in the Device and Control groups", "timeFrame": "12 months"}, {"measure": "Mitral Valve Replacement Rates", "description": "Subjects with mitral valve replacements in the Device and Control groups", "timeFrame": "24 months"}, {"measure": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "timeFrame": "3 years"}, {"measure": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "timeFrame": "4 years"}, {"measure": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "timeFrame": "5 years"}, {"measure": "New Onset of Permanent Atrial Fibrillation", "timeFrame": "12 months"}, {"measure": "New Onset of Permanent Atrial Fibrillation", "timeFrame": "24 months"}, {"measure": "New Onset of Permanent Atrial Fibrillation", "timeFrame": "3 years"}, {"measure": "New Onset of Permanent Atrial Fibrillation", "timeFrame": "4 years"}, {"measure": "New Onset of Permanent Atrial Fibrillation", "timeFrame": "5 years"}, {"measure": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "timeFrame": "12 months"}, {"measure": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "timeFrame": "24 months"}, {"measure": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "timeFrame": "3 years"}, {"measure": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "timeFrame": "4 years"}, {"measure": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "timeFrame": "5 years"}, {"measure": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "timeFrame": "12 months"}, {"measure": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "timeFrame": "24 months"}, {"measure": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "timeFrame": "3 years"}, {"measure": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "timeFrame": "4 years"}, {"measure": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "timeFrame": "5 years"}, {"measure": "Device-related Complications in Device Group Subjects and Control Group Subjects Who Undergo the MitraClip Procedure", "timeFrame": "Through 5 years"}, {"measure": "Brain Natriuretic Peptide (BNP) or N-terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP Levels)", "timeFrame": "Baseline"}, {"measure": "BNP or NT-proBNP Levels", "timeFrame": "30 days"}, {"measure": "BNP or NT-proBNP Levels", "timeFrame": "12 months"}, {"measure": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "timeFrame": "Baseline"}, {"measure": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "timeFrame": "30 days"}, {"measure": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "timeFrame": "6 months"}, {"measure": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "timeFrame": "12 months"}, {"measure": "Major Bleeding", "description": "Major bleeding is defined as bleeding \u2265 Type 3 based on a modified Bleeding Academic Research Consortium (BARC) definition", "timeFrame": "30 days"}, {"measure": "Prolonged Ventilation", "description": "Defined as pulmonary insufficiency requiring ventilatory support for greater than 48 hours post-catheterization", "timeFrame": "30 days"}, {"measure": "Average Dosages of Guideline Directed Medical Therapy (GDMT)", "timeFrame": "Baseline"}, {"measure": "Average Dosages of GDMT", "timeFrame": "30 days"}, {"measure": "Average Dosages of GDMT", "timeFrame": "6 months"}, {"measure": "Average Dosages of GDMT", "timeFrame": "12 months"}, {"measure": "Average Dosages of GDMT", "timeFrame": "24 months"}, {"measure": "Average Dosages of GDMT", "timeFrame": "3 years"}, {"measure": "Average Dosages of GDMT", "timeFrame": "4 years"}, {"measure": "Average Dosages of GDMT", "timeFrame": "5 years"}, {"measure": "The Number of Subjects With Changes in GDMT Dosage From Baseline", "timeFrame": "Between baseline and 30 days"}, {"measure": "The Number of Subjects With Changes in GDMT Dosage From Baseline to 6 Months", "timeFrame": "Between baseline and 6 months"}, {"measure": "The Number of Subjects With Changes in GDMT Dosage From Baseline and 12 Months", "timeFrame": "Between baseline and 12 months"}, {"measure": "The Number of Subjects With Changes in GDMT Dosage From Baseline and 24 Months", "timeFrame": "Between baseline and 24 months"}, {"measure": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "timeFrame": "Between baseline and 3 years"}, {"measure": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "timeFrame": "Between baseline and 4 years"}, {"measure": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "timeFrame": "Between baseline and 5 years"}, {"measure": "The Number of Subjects With Change in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 30 days"}, {"measure": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 6 months"}, {"measure": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 12 months"}, {"measure": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 24 months"}, {"measure": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 3 years"}, {"measure": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 4 years"}, {"measure": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "timeFrame": "Between baseline and 5 years"}, {"measure": "Cardiopulmonary Exercise (CPX) Testing", "description": "A substudy endpoint will utilize peak oxygen consumption oxygen uptake (VO2) as a parameter for cardiopulmonary exercise testing on a total of at least 50 and up to 100 subjects.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "timeFrame": "Baseline"}, {"measure": "Cardiopulmonary Exercise (CPX) Testing", "description": "A substudy endpoint will utilize peak oxygen consumption oxygen uptake (VO2) as a parameter for cardiopulmonary exercise testing on a total of at least 50 and up to 100 subjects.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "timeFrame": "12 months"}, {"measure": "Cardiopulmonary Exercise (CPX) Testing: Mean Changes in Peak VO2", "description": "Mean changes in peak VO2 (ml/kg/min) will be summarized at 12 months from baseline for the subset of patients who complete a CPX test at baseline and 12 months. A comparison of change from baseline between Device and Control groups will be presented.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "timeFrame": "Between baseline and 12 months"}, {"measure": "Health Economic Data", "timeFrame": "Through 5 years"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Symptomatic functional MR (\u22653+) due to cardiomyopathy of either ischemic or non-ischemic etiology determined by assessment of a qualifying transthoracic echocardiogram (TTE) obtained within 90 days and transesophageal echocardiogram (TEE) obtained within 180 days prior to subject registration, with MR severity based principally on the TTE study, confirmed by the Echocardiography Core Lab (ECL). The ECL may request a transesophageal echocardiogram (TEE) to confirm MR etiology.\n\n   Note: Functional MR requires the presence of global or regional left ventricular wall motion abnormalities, which are believed to be the primary cause of the MR. If a flail leaflet or other evidence of degenerative MR is present, the subject is not eligible even if global or regional left ventricular systolic dysfunction is present.\n\n   Note: Qualifying TTE must be obtained after the subject has been stabilized on optimal therapy including Guideline Directed Medical Therapy (GDMT) and at least 30 days after:\n   1. a greater than 100% increase or greater than 50% decrease in dose of GDMT\n   2. revascularization and/or implant of Cardiac Resynchronization Therapy device (CRT or CRT-D) or reprogramming of an implanted CRT or CRT-D that results in increased biventricular pacing (from \\<92% to \u226592%)\n2. In the judgment of the HF specialist investigator at the site, the subject has been adequately treated per applicable standards, including for coronary artery disease, left ventricular dysfunction, mitral regurgitation and heart failure (e.g., with cardiac resynchronization therapy, revascularization, and/or GDMT). The Eligibility Committee must also concur that the subject has been adequately treated.\n3. New York Heart Association (NYHA) Functional Class II, III or ambulatory IV.\n4. The Local Site Heart Team (CT surgeon and HF specialist investigators) and the Central Eligibility Committee concur that surgery will not be offered as a treatment option and that medical therapy is the intended therapy for the subject, even if the subject is randomized to the Control group.\n5. The subject has had at least one hospitalization for heart failure in the 12 months prior to subject registration and/or a corrected brain natriuretic peptide (BNP) \u2265300 pg/ml or corrected n-Terminal pro- brain natriuretic peptide NT-proBNP \u22651500 pg/ml measured within 90 days prior to subject registration (\"corrected\" refers to a 4% reduction in the BNP or NT-proBNP cutoff for every increase of 1 kg/m2 in BMI above a reference BMI of 20 kg/m2).\n\n   Note: BNP or NT-proBNP must be obtained after the subject has been stabilized on GDMT and at least 30 days after:\n   1. a greater than 100% increase or greater than 50% decrease in dose of GDMT\n   2. revascularization and/or implant of Cardiac Resynchronization Therapy device (CRT or CRT-D) or reprogramming of an implanted CRT or CRT-D that results in increased biventricular pacing (from \\<92% to \u226592%).\n6. Left Ventricular Ejection Fraction (LVEF) is \u226520% and \u226450% within 90 days prior to subject registration, assessed by the site using any one of the following methods: echocardiography, contrast left ventriculography, gated blood pool scan or cardiac magnetic resonance imaging (MRI).\n\n   Note: The method must provide a quantitative readout (not a visual assessment).\n7. The primary regurgitant jet is non-commissural, and in the opinion of the MitraClip implanting investigator can be successfully be treated by the MitraClip. If a secondary jet exists, it must be considered clinically insignificant.\n8. Creatine Kinase-MB (CK-MB) obtained within prior 14 days \\< local laboratory Upper Limit of Normal (ULN).\n9. Transseptal catheterization and femoral vein access is determined to be feasible by the MitraClip implanting investigator.\n10. Age 18 years or older.\n11. The subject or the subject's legal representative understands and agrees that should he/she be assigned to the Control group, he/she will be treated with medical therapy and conservative management without surgery and without the MitraClip, either domestically or abroad. If the subject would actively contemplate surgery and/or MitraClip if randomized to Control, he/she should not be registered in this trial.\n12. The subject or the subject's legal representative has been informed of the nature of the trial and agrees to its provisions, including the possibility of randomization to the Control group and returning for all required post-procedure follow-up visits, and has provided written informed consent.\n13. Left Ventricular End Systolic Dimension (LVESD) is \u2264 70 mm assessed by site based on a transthoracic echocardiographic (TTE) obtained within 90 days prior to subject registration.\n\nFor the CPX Sub-study: Subjects have to meet the COAPT study eligibility criteria to be registered in the CPX Sub-study.\n\nCOAPT CAS study Inclusion Criteria:\n\n1. Subjects must meet all of the above COAPT RCT inclusion criteria, and must have national Medicare coverage by the Centers for Medicare and Medicaid Services (CMS).\n\nExclusion Criteria:\n\n1. Chronic Obstructive Pulmonary Disease (COPD) requiring continuous home oxygen therapy or chronic outpatient oral steroid use.\n2. Untreated clinically significant coronary artery disease requiring revascularization.\n3. Coronary artery bypass grafting (CABG) within 30 days prior to subject registration.\n4. Percutaneous coronary intervention within 30 days prior to subject registration.\n5. Transcatheter aortic valve replacement (TAVR) within 30 days prior to subject registration.\n6. Tricuspid valve disease requiring surgery or transcatheter intervention.\n7. Aortic valve disease requiring surgery.\n8. Cerebrovascular accident within 30 days prior to subject registration.\n9. Severe symptomatic carotid stenosis (\\> 70% by ultrasound).\n10. Carotid surgery or stenting within 30 days prior to subject registration.\n11. American College of Cardiology /American Heart Association (ACC/AHA) Stage D heart failure.\n12. Presence of any of the following:\n\n    * Estimated pulmonary artery systolic pressure (PASP) \\> 70 mm Hg assessed by site based on echocardiography or right heart catheterization, unless active vasodilator therapy in the cath lab is able to reduce the pulmonary vascular resistance (PVR) to \\< 3 Wood Units or between 3 and 4.5 Wood Units with v wave less than twice the mean of the pulmonary capillary wedge pressure\n    * Hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, or any other structural heart disease causing heart failure other than dilated cardiomyopathy of either ischemic or non ischemic etiology\n    * Infiltrative cardiomyopathies (e.g., amyloidosis, hemochromatosis, sarcoidosis)\n    * Hemodynamic instability requiring inotropic support or mechanical heart assistance.\n13. Physical evidence of right-sided congestive heart failure with echocardiographic evidence of moderate or severe right ventricular dysfunction as assessed by site.\n14. Implant of any Cardiac Resynchronization Therapy (CRT) or Cardiac Resynchronization Therapy with cardioverter-defibrillator (CRT-D) within the last 30days prior to subject registration.\n15. Mitral valve orifice area \\< 4.0 cm2 assessed by site based on a transthoracic echocardiogram (TTE) within 90 days prior to subject registration.\n16. Leaflet anatomy which may preclude MitraClip implantation, proper MitraClip positioning on the leaflets or sufficient reduction in MR by the MitraClip. This evaluation is based on transesophageal echocardiogram (TEE) evaluation of the mitral valve within 180 days prior to subject registration and includes:\n\n    * Insufficient mobile leaflet available for grasping with the MitraClip device\n    * Evidence of calcification in the grasping area\n    * Presence of a significant cleft in the grasping area\n    * Lack of both primary and secondary chordal support in the grasping area\n    * Leaflet mobility length \\< 1 cm\n17. Hemodynamic instability defined as systolic pressure \\< 90 mmHg with or without afterload reduction, cardiogenic shock or the need for inotropic support or intra-aortic balloon pump or other hemodynamic support device.\n18. Need for emergent or urgent surgery for any reason or any planned cardiac surgery within the next 12 months.\n19. Life expectancy \\< 12 months due to non-cardiac conditions.\n20. Modified Rankin Scale \u2265 4 disability.\n21. Status 1 heart transplant or prior orthotopic heart transplantation.\n22. Prior mitral valve leaflet surgery or any currently implanted prosthetic mitral valve, or any prior transcatheter mitral valve procedure.\n23. Echocardiographic evidence of intracardiac mass, thrombus or vegetation.\n24. Active endocarditis or active rheumatic heart disease or leaflets degenerated from rheumatic disease (i.e., noncompliant, perforated).\n25. Active infections requiring current antibiotic therapy.\n26. Subjects in whom transesophageal echocardiography (TEE) is contraindicated or high risk.\n27. Known hypersensitivity or contraindication to procedural medications which cannot be adequately managed medically.\n28. Pregnant or planning pregnancy within next 12 months.\n\n    Note: Female patients of childbearing age should be instructed to use safe contraception (e.g. intrauterine devices, hormonal contraceptives: contraceptive pills, implants, transdermal patches hormonal vaginal devices, injections with prolonged release.\n29. Currently participating in an investigational drug or another device study that has not reached its primary endpoint. Note: Trials requiring extended follow-up for products that were investigational, but have since become commercially available, are not considered investigational trials.\n30. Subject belongs to a vulnerable population per investigator's judgment or subject has any kind of disorder that compromises his/her ability to give written informed consent and/or to comply with study procedures.\n\nFor the CPX Sub-study: Subjects who have any contraindications to CPX and are not capable of performing CPX per investigator's assessment should not be registered in the CPX Sub-study.\n\nCOAPT CAS study Exclusion Criteria:\n\n1. Subjects must not meet any of the above COAPT RCT exclusion criteria.\n\n.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Michael Mack, MD", "affiliation": "Baylor Health Care System", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Gregg Stone, MD", "affiliation": "MOUNT SINAI HOSPITAL", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "William T Abraham, MD", "affiliation": "The Ohio State University Heart Center", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "JoAnn Lindenfeld, MD", "affiliation": "Vanderbilt University Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of Alabama at Birmingham", "city": "Birmingham", "state": "Alabama", "zip": "35233", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Banner Good Samaritan Medical Center", "city": "Phoenix", "state": "Arizona", "zip": "85006", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Scottsdale Healthcare Hospitals", "city": "Scottsdale", "state": "Arizona", "zip": "85258", "country": "United States", "geoPoint": {"lat": 33.50921, "lon": -111.89903}}, {"facility": "Scripps Green Hospital", "city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"facility": "Cedars-Sinai Medical Center", "city": "Los Angeles", "state": "California", "zip": "90048", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "El Camino Hospital", "city": "Mountain View", "state": "California", "zip": "94040", "country": "United States", "geoPoint": {"lat": 37.38605, "lon": -122.08385}}, {"facility": "University California Davis Medical Center", "city": "Sacramento", "state": "California", "zip": "95817", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Kaiser Permanente - San Francisco Hospital", "city": "San Francisco", "state": "California", "zip": "94115", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "Stanford Hospital and Clinics", "city": "Stanford", "state": "California", "zip": "94305", "country": "United States", "geoPoint": {"lat": 37.42411, "lon": -122.16608}}, {"facility": "University of Colorado Hospital", "city": "Denver", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Hartford Hospital", "city": "Hartford", "state": "Connecticut", "zip": "06106", "country": "United States", "geoPoint": {"lat": 41.76371, "lon": -72.68509}}, {"facility": "Yale - New Haven Hospital", "city": "New Haven", "state": "Connecticut", "zip": "06510", "country": "United States", "geoPoint": {"lat": 41.30815, "lon": -72.92816}}, {"facility": "Medstar Washington Hospital Center", "city": "Washington", "state": "District of Columbia", "zip": "20010", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"facility": "Morton Plant Hospital", "city": "Clearwater", "state": "Florida", "zip": "33756", "country": "United States", "geoPoint": {"lat": 27.96585, "lon": -82.8001}}, {"facility": "Mount Sinai Medical Center", "city": "Miami", "state": "Florida", "zip": "33140", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "Florida Hospital Orlando", "city": "Orlando", "state": "Florida", "zip": "32803", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Sarasota Memorial Hospital", "city": "Sarasota", "state": "Florida", "zip": "34239", "country": "United States", "geoPoint": {"lat": 27.33643, "lon": -82.53065}}, {"facility": "Tallahassee Memorial Hospital", "city": "Tallahassee", "state": "Florida", "zip": "32308", "country": "United States", "geoPoint": {"lat": 30.43826, "lon": -84.28073}}, {"facility": "Tampa General Hospital", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Piedmont Hospital Atlanta", "city": "Atlanta", "state": "Georgia", "zip": "30309", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Emory University Hospital", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "The Queen's Medical Center", "city": "Honolulu", "state": "Hawaii", "zip": "96813", "country": "United States", "geoPoint": {"lat": 21.30694, "lon": -157.85833}}, {"facility": "Northwestern Memorial Hospital", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Rush University Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Evanston Hospital", "city": "Evanston", "state": "Illinois", "zip": "60201", "country": "United States", "geoPoint": {"lat": 42.04114, "lon": -87.69006}}, {"facility": "St. Vincent Heart Center of Indiana", "city": "Indianapolis", "state": "Indiana", "zip": "46290", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "Iowa Heart Center", "city": "Des Moines", "state": "Iowa", "zip": "50266", "country": "United States", "geoPoint": {"lat": 41.60054, "lon": -93.60911}}, {"facility": "University of Kansas Hosp Authority", "city": "Kansas City", "state": "Kansas", "zip": "66160", "country": "United States", "geoPoint": {"lat": 39.11417, "lon": -94.62746}}, {"facility": "Via Christi", "city": "Wichita", "state": "Kansas", "zip": "66866", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "St. Joseph's Hospital - Lexington, KY", "city": "Lexington", "state": "Kentucky", "zip": "40504", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Jewish Hospital", "city": "Louisville", "state": "Kentucky", "zip": "40245", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "Ochsner Clinic Foundation", "city": "New Orleans", "state": "Louisiana", "zip": "70121", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Maine Medical Center", "city": "Portland", "state": "Maine", "zip": "04102", "country": "United States", "geoPoint": {"lat": 43.66147, "lon": -70.25533}}, {"facility": "University of Maryland Baltimore", "city": "Baltimore", "state": "Maryland", "zip": "21201", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Tufts Medical Center", "city": "Boston", "state": "Massachusetts", "zip": "02111", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Massachusetts General Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02114", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Brigham and Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "University of Michigan Hospitals", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "Henry Ford Hospital", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "William Beaumont Hospital", "city": "Royal Oak", "state": "Michigan", "zip": "48073-6796", "country": "United States", "geoPoint": {"lat": 42.48948, "lon": -83.14465}}, {"facility": "Abbott Northwestern Hospital", "city": "Minneapolis", "state": "Minnesota", "zip": "55407", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "University of Minnesota", "city": "Minneapolis", "state": "Minnesota", "zip": "55455", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "Mayo Foundation for Med Edu And Research", "city": "Rochester", "state": "Minnesota", "zip": "55905", "country": "United States", "geoPoint": {"lat": 44.02163, "lon": -92.4699}}, {"facility": "Saint Luke's Hospital", "city": "Kansas City", "state": "Missouri", "zip": "64111", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "Barnes Jewish Hospital", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "St. Patrick Hospital", "city": "Missoula", "state": "Montana", "zip": "59802", "country": "United States", "geoPoint": {"lat": 46.87215, "lon": -113.994}}, {"facility": "Nebraska Heart Institute Heart Hospital", "city": "Lincoln", "state": "Nebraska", "zip": "68526", "country": "United States", "geoPoint": {"lat": 40.8, "lon": -96.66696}}, {"facility": "Cooper University Hospital", "city": "Camden", "state": "New Jersey", "zip": "08103", "country": "United States", "geoPoint": {"lat": 39.92595, "lon": -75.11962}}, {"facility": "Morristown Medical Center", "city": "Morristown", "state": "New Jersey", "zip": "07960", "country": "United States", "geoPoint": {"lat": 40.79677, "lon": -74.48154}}, {"facility": "North Shore", "city": "Manhasset", "state": "New York", "zip": "11030", "country": "United States", "geoPoint": {"lat": 40.79788, "lon": -73.69957}}, {"facility": "NYU Langone Medical Center", "city": "New York", "state": "New York", "zip": "10016", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Mount Sinai Medical Center", "city": "New York", "state": "New York", "zip": "10029", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Columbia University Medical Center / New York Presbyterian Hospital", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "NYP Weill Cornell Medical Center", "city": "New York", "state": "New York", "zip": "10065", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "St. Francis Hospital", "city": "Roslyn", "state": "New York", "zip": "11576", "country": "United States", "geoPoint": {"lat": 40.79982, "lon": -73.65096}}, {"facility": "Carolinas Medical Center", "city": "Charlotte", "state": "North Carolina", "zip": "28203", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Duke University Medical Center", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "Vidant Medical Center", "city": "Greenville", "state": "North Carolina", "zip": "27834", "country": "United States", "geoPoint": {"lat": 35.61266, "lon": -77.36635}}, {"facility": "The Christ Hospital", "city": "Cincinnati", "state": "Ohio", "zip": "45219", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Cleveland Clinic", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Ohio State University Medical Center", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Riverside Methodist Hospital", "city": "Columbus", "state": "Ohio", "zip": "43214-3907", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Oklahoma Heart Hospital", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Providence St. Vincent Medical Center", "city": "Portland", "state": "Oregon", "zip": "97225", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Oregon Health and Science University", "city": "Portland", "state": "Oregon", "zip": "97239", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Hospital of University Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Temple University Hospital", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19140", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "UPMC Presbyterian", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15213", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Pinnacle Health at Harrisburg Hospital", "city": "Wormleysburg", "state": "Pennsylvania", "zip": "17043", "country": "United States", "geoPoint": {"lat": 40.26287, "lon": -76.91386}}, {"facility": "Medical University of South Carolina", "city": "Charleston", "state": "South Carolina", "zip": "29403", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "St. Thomas Hospital", "city": "Nashville", "state": "Tennessee", "zip": "37205", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Seton Medical Center Austin", "city": "Austin", "state": "Texas", "zip": "78705", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "Baylor Heart and Vascular Hospital", "city": "Dallas", "state": "Texas", "zip": "75204", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "UT Southwestern Medical Center", "city": "Dallas", "state": "Texas", "zip": "75235", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Houston Methodist Hospital", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Memorial Hermann Hospital", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Intermountain Medical Center", "city": "Murray", "state": "Utah", "zip": "84107", "country": "United States", "geoPoint": {"lat": 40.66689, "lon": -111.88799}}, {"facility": "University of Virginia", "city": "Charlottesville", "state": "Virginia", "zip": "22908", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "Virginia Commonwealth University Medical Center", "city": "Richmond", "state": "Virginia", "zip": "23284", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "Carilion Roanoke Memorial Hospital", "city": "Roanoke", "state": "Virginia", "zip": "24014", "country": "United States", "geoPoint": {"lat": 37.27097, "lon": -79.94143}}, {"facility": "Swedish Medical Center Cherry Hill Campus", "city": "Seattle", "state": "Washington", "zip": "98122", "country": "United States", "geoPoint": {"lat": 47.60621, "lon": -122.33207}}, {"facility": "St Paul's - Providence Health Care", "city": "Vancouver", "state": "British Columbia", "zip": "V6Z 1Y6", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Hamilton Health Sciences", "city": "Hamilton", "state": "Ontario", "zip": "L8L 2X2", "country": "Canada", "geoPoint": {"lat": 43.25011, "lon": -79.84963}}, {"facility": "St Michael's Hospital", "city": "Toronto", "state": "Ontario", "zip": "M5B 1W8", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Montreal Heart Institute", "city": "Montreal", "state": "Quebec", "zip": "H1T 1C8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "University of Alberta", "city": "Edmonton", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}]}, "referencesModule": {"references": [{"pmid": "36357085", "type": "DERIVED", "citation": "Giustino G, Camaj A, Kapadia SR, Kar S, Abraham WT, Lindenfeld J, Lim DS, Grayburn PA, Cohen DJ, Redfors B, Zhou Z, Pocock SJ, Asch FM, Mack MJ, Stone GW. Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial. J Am Coll Cardiol. 2022 Nov 15;80(20):1857-1868. doi: 10.1016/j.jacc.2022.08.803."}, {"pmid": "34674862", "type": "DERIVED", "citation": "Brener MI, Grayburn P, Lindenfeld J, Burkhoff D, Liu M, Zhou Z, Alu MC, Medvedofsky DA, Asch FM, Weissman NJ, Bax J, Abraham W, Mack MJ, Stone GW, Hahn RT. Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial. JACC Cardiovasc Interv. 2021 Oct 25;14(20):2231-2242. doi: 10.1016/j.jcin.2021.07.047."}, {"pmid": "34391744", "type": "DERIVED", "citation": "Kosmidou I, Lindenfeld J, Abraham WT, Rinaldi MJ, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Gaba P, Rogers JH, Shahim B, Redfors B, Zhang Z, Mack MJ, Stone GW. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure. JACC Heart Fail. 2021 Sep;9(9):674-683. doi: 10.1016/j.jchf.2021.04.011. Epub 2021 Aug 11."}, {"pmid": "34391740", "type": "DERIVED", "citation": "Arnold SV, Stone GW, Jain SS, Mack MJ, Saxon JT, Zhang Z, Lindenfeld J, Abraham WT, Cohen DJ; COAPT Investigators. Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation. JACC Heart Fail. 2021 Sep;9(9):684-692. doi: 10.1016/j.jchf.2021.04.012. Epub 2021 Aug 11."}, {"pmid": "34325886", "type": "DERIVED", "citation": "Shahim B, Ben-Yehuda O, Chen S, Redfors B, Madhavan MV, Kar S, Lim DS, Asch FM, Weissman NJ, Cohen DJ, Arnold SV, Liu M, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT Trial. JACC Heart Fail. 2021 Aug;9(8):559-567. doi: 10.1016/j.jchf.2021.03.011."}, {"pmid": "34039025", "type": "DERIVED", "citation": "Kar S, Mack MJ, Lindenfeld J, Abraham WT, Asch FM, Weissman NJ, Enriquez-Sarano M, Lim DS, Mishell JM, Whisenant BK, Rogers JH, Arnold SV, Cohen DJ, Grayburn PA, Stone GW. Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: COAPT Trial. Circulation. 2021 Aug 10;144(6):426-437. doi: 10.1161/CIRCULATIONAHA.120.053061. Epub 2021 May 27."}, {"pmid": "33719505", "type": "DERIVED", "citation": "Gertz ZM, Herrmann HC, Lim DS, Kar S, Kapadia SR, Reed GW, Puri R, Krishnaswamy A, Gersh BJ, Weissman NJ, Asch FM, Grayburn PA, Kosmidou I, Redfors B, Zhang Z, Abraham WT, Lindenfeld J, Stone GW, Mack MJ. Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial. Circ Cardiovasc Interv. 2021 Apr;14(4):e010300. doi: 10.1161/CIRCINTERVENTIONS.120.010300. Epub 2021 Mar 15."}, {"pmid": "33632476", "type": "DERIVED", "citation": "Mack MJ, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant BK, Grayburn PA, Rinaldi MJ, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Rogers JH, Marx SO, Cohen DJ, Weissman NJ, Stone GW; COAPT Investigators. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure. J Am Coll Cardiol. 2021 Mar 2;77(8):1029-1040. doi: 10.1016/j.jacc.2020.12.047."}, {"pmid": "33533873", "type": "DERIVED", "citation": "Lindenfeld J, Abraham WT, Grayburn PA, Kar S, Asch FM, Lim DS, Nie H, Singhal P, Sundareswaran KS, Weissman NJ, Mack MJ, Stone GW; Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Investigators. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial. JAMA Cardiol. 2021 Apr 1;6(4):427-436. doi: 10.1001/jamacardio.2020.7200."}, {"pmid": "33303119", "type": "DERIVED", "citation": "Saxon JT, Cohen DJ, Chhatriwalla AK, Kotinkaduwa LN, Kar S, Lim DS, Abraham WT, Lindenfeld J, Mack MJ, Arnold SV, Stone GW. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial. JACC Cardiovasc Interv. 2020 Dec 14;13(23):2795-2803. doi: 10.1016/j.jcin.2020.09.023."}, {"pmid": "33176460", "type": "DERIVED", "citation": "Kosmidou I, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant BK, Kipperman RM, Boudoulas KD, Redfors B, Shahim B, Zhang Z, Mack MJ, Stone GW. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial. Circ Heart Fail. 2020 Nov;13(11):e007293. doi: 10.1161/CIRCHEARTFAILURE.120.007293. Epub 2020 Nov 12."}, {"pmid": "33092705", "type": "DERIVED", "citation": "Giustino G, Lindenfeld J, Abraham WT, Kar S, Lim DS, Grayburn PA, Kapadia SR, Cohen DJ, Kotinkaduwa LN, Weissman NJ, Mack MJ, Stone GW. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. JACC Cardiovasc Interv. 2020 Oct 26;13(20):2317-2328. doi: 10.1016/j.jcin.2020.06.058."}, {"pmid": "32912445", "type": "DERIVED", "citation": "Hahn RT, Asch F, Weissman NJ, Grayburn P, Kar S, Lim S, Ben-Yehuda O, Shahim B, Chen S, Liu M, Redfors B, Medvedofsky D, Puri R, Kapadia S, Sannino A, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. J Am Coll Cardiol. 2020 Sep 15;76(11):1305-1314. doi: 10.1016/j.jacc.2020.07.035."}, {"pmid": "32854834", "type": "DERIVED", "citation": "Grayburn PA, Sannino A, Cohen DJ, Kar S, Lim DS, Mishell JM, Whisenant BK, Rinaldi MJ, Kapadia SR, Rajagopal V, Crowley A, Kotinkaduwa LN, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial. J Am Coll Cardiol. 2020 Sep 1;76(9):1007-1014. doi: 10.1016/j.jacc.2020.07.010."}, {"pmid": "32194195", "type": "DERIVED", "citation": "Arnold SV, Stone GW, Mack MJ, Chhatriwalla AK, Austin BA, Zhang Z, Ben-Yehuda O, Kar S, Lim DS, Lindenfeld J, Abraham WT, Cohen DJ; COAPT Investigators. Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial. J Am Coll Cardiol. 2020 May 5;75(17):2099-2106. doi: 10.1016/j.jacc.2020.03.002. Epub 2020 Mar 16."}, {"pmid": "31865965", "type": "DERIVED", "citation": "Tang GHL. Echocardiographic Understanding of Secondary Mitral Regurgitation in Transcatheter Mitral Valve Repair: More to Learn. J Am Coll Cardiol. 2019 Dec 17;74(24):2980-2981. doi: 10.1016/j.jacc.2019.11.001. Epub 2019 Dec 9. No abstract available."}, {"pmid": "31574303", "type": "DERIVED", "citation": "Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG, Mishell JM, Whisenant B, Mack MJ, Lindenfeld J, Abraham WT, Stone GW, Weissman NJ; COAPT Investigators. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial. J Am Coll Cardiol. 2019 Dec 17;74(24):2969-2979. doi: 10.1016/j.jacc.2019.09.017. Epub 2019 Sep 28."}, {"pmid": "31564137", "type": "DERIVED", "citation": "Baron SJ, Wang K, Arnold SV, Magnuson EA, Whisenant B, Brieke A, Rinaldi M, Asgar AW, Lindenfeld J, Abraham WT, Mack MJ, Stone GW, Cohen DJ; COAPT Investigators. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial. Circulation. 2019 Dec 3;140(23):1881-1891. doi: 10.1161/CIRCULATIONAHA.119.043275. Epub 2019 Sep 29."}, {"pmid": "30894288", "type": "DERIVED", "citation": "Arnold SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, Baron SJ, Kar S, Lim DS, Mishell JM, Abraham WT, Lindenfeld JA, Mack MJ, Stone GW, Cohen DJ; COAPT Investigators. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial. J Am Coll Cardiol. 2019 May 7;73(17):2123-2132. doi: 10.1016/j.jacc.2019.02.010. Epub 2019 Mar 17."}, {"pmid": "30280640", "type": "DERIVED", "citation": "Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23."}, {"pmid": "30134187", "type": "DERIVED", "citation": "Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. Am Heart J. 2018 Nov;205:1-11. doi: 10.1016/j.ahj.2018.07.021. Epub 2018 Aug 1."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "This section includes the results for the primary safety, primary effectiveness, and the 10 secondary endpoints that are the most essential outcomes of the COAPT trial and also the Primary safety, primary effectiveness and other endpoints for the COAPT CAS Group.", "recruitmentDetails": "In COAPT, 614 subjects were randomized. Enrollment concluded on June 23, 2017. Of the 614 randomized subjects, 302 were in Device group and 312 in the Control group. Subject follow-up is complete in the COAPT IDE study.\n\nIn COAPT CAS Group, 162 new subjects were enrolled. All 162 subjects received MitraClip device. Enrollment concluded in March 2019. Subject follow-up is on-going in the COAPT CAS study.\n\nTotal enrollment = 614 (COAPT = 302 MitraClip + 314 Control) + 162 (COAPT CAS) = 776", "groups": [{"id": "FG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "FG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}, {"id": "FG002", "title": "COAPT CAS Group", "description": "162 Subjects enrolled in the COAPT Continued access study (CAS) group.\n\nSubject follow-up until occurred until 12-month visit."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "302"}, {"groupId": "FG001", "numSubjects": "312"}, {"groupId": "FG002", "numSubjects": "162"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "104"}, {"groupId": "FG001", "numSubjects": "75"}, {"groupId": "FG002", "numSubjects": "110"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "198"}, {"groupId": "FG001", "numSubjects": "237"}, {"groupId": "FG002", "numSubjects": "52"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "167"}, {"groupId": "FG001", "numSubjects": "192"}, {"groupId": "FG002", "numSubjects": "39"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "23"}, {"groupId": "FG001", "numSubjects": "37"}, {"groupId": "FG002", "numSubjects": "5"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "2"}]}, {"type": "Missed Visits", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "6"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Of the 614 subjects, 302 from MitraClip system group and 312 from Control group completed the baseline visit.\n\n162 subjects enrolled in the COAPT CAS group", "groups": [{"id": "BG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "BG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}, {"id": "BG002", "title": "COAPT CAS Group", "description": "subjects who received Percutaneous mitral valve repair using MitraClip System in the COAPT continued access study (CAS) group."}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "71.7", "spread": "11.8"}, {"groupId": "BG001", "value": "72.8", "spread": "10.5"}, {"groupId": "BG002", "value": "74.5", "spread": "10.3"}, {"groupId": "BG003", "value": "72.2", "spread": "11.2"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "101"}, {"groupId": "BG001", "value": "120"}, {"groupId": "BG002", "value": "57"}, {"groupId": "BG003", "value": "278"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "201"}, {"groupId": "BG001", "value": "192"}, {"groupId": "BG002", "value": "105"}, {"groupId": "BG003", "value": "498"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Race/Ethnicity", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "23"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "44"}, {"groupId": "BG001", "value": "44"}, {"groupId": "BG002", "value": "28"}, {"groupId": "BG003", "value": "116"}]}, {"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "40"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}, {"title": "White or Caucasian", "measurements": [{"groupId": "BG000", "value": "225"}, {"groupId": "BG001", "value": "232"}, {"groupId": "BG002", "value": "129"}, {"groupId": "BG003", "value": "586"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "10"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Canada", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "26"}]}]}, {"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "290"}, {"groupId": "BG001", "value": "298"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "588"}]}]}]}, {"title": "Height", "populationDescription": "Data is missing for 1 subject in Device group and 6 subjects in control group", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Cm", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "306"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "769"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "170.84", "spread": "10.35"}, {"groupId": "BG001", "value": "169.86", "spread": "10.75"}, {"groupId": "BG002", "value": "171.11", "spread": "10.38"}, {"groupId": "BG003", "value": "170.34", "spread": "10.56"}]}]}]}, {"title": "Weight", "populationDescription": "Data is missing for 1 subject in Device group and 5 subjects in Control group.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Kg", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "307"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "770"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "78.79", "spread": "17.23"}, {"groupId": "BG001", "value": "78.40", "spread": "20.06"}, {"groupId": "BG002", "value": "79.08", "spread": "18.76"}, {"groupId": "BG003", "value": "78.59", "spread": "18.70"}]}]}]}, {"title": "Body Mass Index (kg/m^2)", "populationDescription": "Data is missing for 2 subjects for Device and 7 subjects for Control group.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Kg/m^2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "305"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "768"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "27.04", "spread": "5.81"}, {"groupId": "BG001", "value": "27.05", "spread": "5.96"}, {"groupId": "BG002", "value": "26.93", "spread": "5.63"}, {"groupId": "BG003", "value": "27.05", "spread": "5.88"}]}]}]}, {"title": "Serum Creatinine (mg/dL)", "populationDescription": "Data is missing for 2 subjects in Device group and 6 subjects in Control group.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "(mg/dL)", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "300"}, {"groupId": "BG001", "value": "306"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "768"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1.77", "spread": "1.22"}, {"groupId": "BG001", "value": "1.80", "spread": "1.42"}, {"groupId": "BG002", "value": "1.93", "spread": "1.54"}, {"groupId": "BG003", "value": "1.79", "spread": "1.32"}]}]}]}, {"title": "Creatinine Clearance (mL/min)", "populationDescription": "Data is missing for 3 subjects in Device group and 10 subjects in Control group.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mL/min", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "299"}, {"groupId": "BG001", "value": "302"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "763"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "50.87", "spread": "28.48"}, {"groupId": "BG001", "value": "47.76", "spread": "24.97"}, {"groupId": "BG002", "value": "0", "spread": "0"}, {"groupId": "BG003", "value": "49.31", "spread": "26.79"}]}]}]}, {"title": "Creatinine Clearance <= 60mL/min", "populationDescription": "Data is missing for 3 subjects in Device group and 10 subjects in Control group", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "299"}, {"groupId": "BG001", "value": "302"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "763"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "214"}, {"groupId": "BG001", "value": "227"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "441"}]}]}]}, {"title": "Brain Natriuretic Peptide (Pg/mL)", "populationDescription": "Not all subjects had Brain Natriuretic Peptide (BNP) value collected. some subjects were on NT-proBNP.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Pg/mL", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "208"}, {"groupId": "BG001", "value": "209"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "579"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1014.77", "spread": "1085.98"}, {"groupId": "BG001", "value": "1017.13", "spread": "1212.77"}, {"groupId": "BG002", "value": "1224.2", "spread": "1270.4"}, {"groupId": "BG003", "value": "1015.95", "spread": "1149.89"}]}]}]}, {"title": "NT-proBNP (pg/mL)", "populationDescription": "Majority of subjects had BNP available. Subjects who did not have BNP had NT-proBNP available.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "pg/mL", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "74"}, {"groupId": "BG001", "value": "85"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "321"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "5174.33", "spread": "6566.61"}, {"groupId": "BG001", "value": "5943.86", "spread": "8437.61"}, {"groupId": "BG002", "value": "6885.3", "spread": "8287.0"}, {"groupId": "BG003", "value": "5585.71", "spread": "7610.56"}]}]}]}, {"title": "Elevated BNP or NT-BNP prior to Enrollment", "populationDescription": "All available data reported", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "286"}, {"groupId": "BG001", "value": "303"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "751"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "267"}, {"groupId": "BG001", "value": "282"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "549"}]}]}]}, {"title": "Extremely High Risk for MV Surgery", "description": "High surgical risk if investigational site assessed a predicted surgical mortality for mitral valve surgery of \u2265 12% based on either:\n\nI) STS (Society of Thoracic Surgeons) mortality risk \u2265 12%, or\n\nII) The presence of at least one of the following:\n\n1. Porcelain aorta or mobile ascending aortic atheroma\n2. Post-radiation mediastinum\n3. Previous mediastinitis\n4. Functional MR with EF \\< 40%\n5. Over 75 years old with EF \\< 40%\n6. Prior re-operation with patent grafts\n7. Two or more prior chest surgeries\n8. Hepatic cirrhosis\n9. Three or more of the following STS high risk factors", "populationDescription": "Not all subjects met the criteria for High Risk for MV Surgery", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "299"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "773"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "205"}, {"groupId": "BG001", "value": "218"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "423"}]}]}]}, {"title": "Diabetes", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "106"}, {"groupId": "BG001", "value": "123"}, {"groupId": "BG002", "value": "51"}, {"groupId": "BG003", "value": "280"}]}]}]}, {"title": "Hypertension", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "243"}, {"groupId": "BG001", "value": "251"}, {"groupId": "BG002", "value": "137"}, {"groupId": "BG003", "value": "631"}]}]}]}, {"title": "Hypercholesterolemia", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "166"}, {"groupId": "BG001", "value": "163"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "329"}]}]}]}, {"title": "Previous Myocardial Infarction", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "156"}, {"groupId": "BG001", "value": "160"}, {"groupId": "BG002", "value": "65"}, {"groupId": "BG003", "value": "381"}]}]}]}, {"title": "Previous Percutaneous Coronary Intervention", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "130"}, {"groupId": "BG001", "value": "153"}, {"groupId": "BG002", "value": "63"}, {"groupId": "BG003", "value": "346"}]}]}]}, {"title": "Previous Coronary Artery Bypass Grafting", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "121"}, {"groupId": "BG001", "value": "126"}, {"groupId": "BG002", "value": "51"}, {"groupId": "BG003", "value": "298"}]}]}]}, {"title": "Previous Stroke or Transient Ischemic Attack", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "56"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "114"}]}]}]}, {"title": "Peripheral Vascular Disease", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "52"}, {"groupId": "BG001", "value": "57"}, {"groupId": "BG002", "value": "34"}, {"groupId": "BG003", "value": "143"}]}]}]}, {"title": "Chronic Obstructive Pulmonary Disease", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "71"}, {"groupId": "BG001", "value": "72"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "143"}]}]}]}, {"title": "History of Atrial Fibrillation or Flutter", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "173"}, {"groupId": "BG001", "value": "166"}, {"groupId": "BG002", "value": "99"}, {"groupId": "BG003", "value": "438"}]}]}]}, {"title": "Anemia", "populationDescription": "All available data is reported", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "306"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "769"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "180"}, {"groupId": "BG001", "value": "192"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "372"}]}]}]}, {"title": "STS Risk Score", "description": "The STS score is a validated risk-prediction model for open surgery based on data from the STS National Adult Cardiac Surgery Database. In general, an STS predicted risk of surgical mortality of 4%-8% is considered intermediate risk and 8% or greater is considered high risk.\n\nAs of November 15, 2018, The Society of Thoracic Surgeons released an updated short-term risk calculator to reflect the latest 2018 adult cardiac surgery risk models. The STS Calculator allows you to calculate a patient's risk of mortality and morbidities for the most commonly performed cardiac surgeries.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percentage of expected mortality", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "7.83", "spread": "5.53"}, {"groupId": "BG001", "value": "8.5", "spread": "6.15"}, {"groupId": "BG002", "value": "9.26", "spread": "6.39"}, {"groupId": "BG003", "value": "8.17", "spread": "5.86"}]}]}]}, {"title": "STS Risk Score >= 8%", "description": "The STS score is a validated risk-prediction model for open surgery based on data from the STS National Adult Cardiac Surgery Database. In general, an STS predicted risk of surgical mortality of 4%-8% is considered intermediate risk and 8% or greater is considered high risk.\n\nAs of November 15, 2018, The Society of Thoracic Surgeons released an updated short-term risk calculator to reflect the latest 2018 adult cardiac surgery risk models. The STS Calculator allows you to calculate a patient's risk of mortality and morbidities for the most commonly performed cardiac surgeries.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "126"}, {"groupId": "BG001", "value": "136"}, {"groupId": "BG002", "value": "78"}, {"groupId": "BG003", "value": "340"}]}]}]}, {"title": "Risk of Surgery-related complications or death", "description": "Subjects were evaluated by the Local Site Heart Team based on their medical history to determine their risk of surgery related complications or death.", "populationDescription": "All available data is reported", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "High", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "299"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "773"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "205"}, {"groupId": "BG001", "value": "218"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "423"}]}]}, {"title": "Not High", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "299"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "773"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "94"}, {"groupId": "BG001", "value": "94"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "188"}]}]}]}, {"title": "Cardiomyopathy", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Ischemic", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "184"}, {"groupId": "BG001", "value": "189"}, {"groupId": "BG002", "value": "73"}, {"groupId": "BG003", "value": "446"}]}]}, {"title": "Non-Ischemic", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "118"}, {"groupId": "BG001", "value": "123"}, {"groupId": "BG002", "value": "66"}, {"groupId": "BG003", "value": "307"}]}]}]}, {"title": "New York Heart Association (NYHA) Classification", "description": "The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I - No symptoms and no limitation in ordinary physical activity Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.\n\nClass III - Marked limitation in activity due to symptoms Class IV - Severe limitations.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "NYHA Class I", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}]}, {"title": "NYHA Class II", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "129"}, {"groupId": "BG001", "value": "110"}, {"groupId": "BG002", "value": "30"}, {"groupId": "BG003", "value": "269"}]}]}, {"title": "NYHA Class III", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "154"}, {"groupId": "BG001", "value": "168"}, {"groupId": "BG002", "value": "111"}, {"groupId": "BG003", "value": "433"}]}]}, {"title": "NYHA Class IVa, ambulatory", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "33"}, {"groupId": "BG002", "value": "21"}, {"groupId": "BG003", "value": "72"}]}]}]}, {"title": "Hospitalization for Heart Failure within Previous 1 yr", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "176"}, {"groupId": "BG001", "value": "175"}, {"groupId": "BG002", "value": "105"}, {"groupId": "BG003", "value": "456"}]}]}]}, {"title": "Previous Cardiac Resynchronization Therapy", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "115"}, {"groupId": "BG001", "value": "109"}, {"groupId": "BG002", "value": "25"}, {"groupId": "BG003", "value": "249"}]}]}]}, {"title": "Previous Implantation of Defibrillator", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "312"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "776"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "91"}, {"groupId": "BG001", "value": "101"}, {"groupId": "BG002", "value": "95"}, {"groupId": "BG003", "value": "287"}]}]}]}, {"title": "Severity of Mitral Regurgitation", "populationDescription": "In the Control group, baseline echocardiography data was not readable. Hence 311 participants were analyzed.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Moderate-to-severe, grade 3+", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "311"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "775"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "148"}, {"groupId": "BG001", "value": "172"}, {"groupId": "BG002", "value": "54"}, {"groupId": "BG003", "value": "374"}]}]}, {"title": "Severe, grade 4+", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "302"}, {"groupId": "BG001", "value": "311"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "775"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "154"}, {"groupId": "BG001", "value": "139"}, {"groupId": "BG002", "value": "99"}, {"groupId": "BG003", "value": "392"}]}]}]}, {"title": "Effective Regurgitat Orifice Area", "populationDescription": "EROA was not measurable for all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Cm2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "289"}, {"groupId": "BG001", "value": "302"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "753"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0.41", "spread": "0.15"}, {"groupId": "BG001", "value": "0.40", "spread": "0.15"}, {"groupId": "BG002", "value": "0.70", "spread": "1.16"}, {"groupId": "BG003", "value": "0.41", "spread": "0.15"}]}]}]}, {"title": "Left Ventricular End Systolic Dimension (Diameter)", "description": "left ventricle end-systolic diameter, is measured at end systole, on the frame preceding mitral valve opening. It corresponds to the smallest cardiac dimension.", "populationDescription": "LVESD was not measurable for all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "cm", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "306"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "769"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "5.28", "spread": "0.86"}, {"groupId": "BG001", "value": "5.30", "spread": "0.89"}, {"groupId": "BG002", "value": "1.16", "spread": "0.95"}, {"groupId": "BG003", "value": "5.29", "spread": "0.87"}]}]}]}, {"title": "Left Ventricular End-Diastolic Dimension", "populationDescription": "LVEDD was not measurable in all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "cm", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "301"}, {"groupId": "BG001", "value": "307"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "770"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6.17", "spread": "0.73"}, {"groupId": "BG001", "value": "6.19", "spread": "0.75"}, {"groupId": "BG002", "value": "6.23", "spread": "0.86"}, {"groupId": "BG003", "value": "6.18", "spread": "0.74"}]}]}]}, {"title": "Left Ventricular End-Systolic Volume", "populationDescription": "LVESV was not measurable for all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mL", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "281"}, {"groupId": "BG001", "value": "294"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "737"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "135.5", "spread": "56.1"}, {"groupId": "BG001", "value": "134.3", "spread": "60.3"}, {"groupId": "BG002", "value": "132.3", "spread": "65.4"}, {"groupId": "BG003", "value": "134.9", "spread": "58.2"}]}]}]}, {"title": "Left Ventricular End-Diastolic Volume", "populationDescription": "LVEDV was not measurable in all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mL", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "281"}, {"groupId": "BG001", "value": "294"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "737"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "194.4", "spread": "69.2"}, {"groupId": "BG001", "value": "191.0", "spread": "72.9"}, {"groupId": "BG002", "value": "185.8", "spread": "81.2"}, {"groupId": "BG003", "value": "192.7", "spread": "71.0"}]}]}]}, {"title": "Left Ventricular Ejection Fraction", "populationDescription": "LVEF was not measured for all subjects", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "%", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "281"}, {"groupId": "BG001", "value": "294"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "737"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "31.32", "spread": "9.07"}, {"groupId": "BG001", "value": "31.30", "spread": "9.58"}, {"groupId": "BG002", "value": "32.2", "spread": "9.9"}, {"groupId": "BG003", "value": "31.31", "spread": "9.32"}]}]}]}, {"title": "LVEF >= 40%", "populationDescription": "All available data is reported", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "281"}, {"groupId": "BG001", "value": "294"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "737"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "231"}, {"groupId": "BG001", "value": "241"}, {"groupId": "BG002", "value": "28"}, {"groupId": "BG003", "value": "500"}]}]}]}, {"title": "Right Ventricular Systolic Pressure", "populationDescription": "All available data is reported", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmHg", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "253"}, {"groupId": "BG001", "value": "275"}, {"groupId": "BG002", "value": "162"}, {"groupId": "BG003", "value": "690"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "43.95", "spread": "13.44"}, {"groupId": "BG001", "value": "44.56", "spread": "13.96"}, {"groupId": "BG002", "value": "0", "spread": "0"}, {"groupId": "BG003", "value": "44.26", "spread": "13.70"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Primary Safety Endpoint - Percentage of Participants With Freedom From Device Related Complications at 12 Months", "description": "Percentage of Participants with Freedom from Device related Complications at 12 Months.\n\nComposite of Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, and any device related complications requiring non-elective cardiovascular surgery.", "populationDescription": "Subjects who were randomized with attempted procedure to the device group with available data. Performance goal was 88%.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "293"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.966", "lowerLimit": "0.948", "upperLimit": "NA", "comment": "Upper limit is NA as this is a one sided 95% confidence interval."}]}]}], "analyses": [{"groupIds": ["OG000"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Two thousand (2000) simulations were performed to calculate sample size and power for the primary safety endpoint. Assuming 22% mortality and 7.5% attrition at 12 months, a total of 305 subjects in the Device group will provide \\> 95% power to reject the null hypothesis at the one-sided significance level of 5%.", "pValue": "<0.0001", "statisticalMethod": "Z test Using Kaplan Meier Survival", "statisticalComment": "P-value calculated from Z test using Kaplan Meier survival estimate together with Greenwood method estimated variance", "paramType": "Kaplan Meier", "paramValue": "0.966", "ciPctValue": "95", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "0.948", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.011"}]}, {"type": "PRIMARY", "title": "Primary Effectiveness Endpoint", "description": "Recurrent HF hospitalizations (HFH) through 24 months, analyzed when the last subject completes 12-month follow-up", "populationDescription": "302 subjects from device group and 312 subjects from the control group were analyzed for Recurrent HF hospitalizations through 24 months", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "160"}, {"groupId": "OG001", "value": "283"}]}]}]}, {"type": "PRIMARY", "title": "Primary Effectiveness Endpoint", "description": "Recurrent HF hospitalizations (HFH) through 24 months, analyzed when the last subject completes 12-month follow-up", "populationDescription": "302 subjects from device group and 312 subjects from the control group were analyzed for Recurrent HF hospitalizations through 24 months", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "calculatePct": false, "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "151"}]}]}]}, {"type": "SECONDARY", "title": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "description": "Number of recurrent Heart Failure hospitalization events at 12 months.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Events", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "52"}]}]}]}, {"type": "SECONDARY", "title": "New York Heart Association (NYHA) Functional Class (COAPT CAS Study Analysis)", "description": "The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I - No symptoms and no limitation in ordinary physical activity Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class III - Marked limitation in activity due to symptoms Class IV - Severe limitations.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. Of them NYHA data was available for a total of 93 subjects at 12 months.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "93"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "21"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "44"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "23"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "5"}]}]}]}, {"type": "SECONDARY", "title": "New York Heart Association (NYHA) Functional Class (COAPT CAS Study Analysis)", "description": "The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I - No symptoms and no limitation in ordinary physical activity Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class III - Marked limitation in activity due to symptoms Class IV - Severe limitations.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. Of them NYHA data was available for a total of 142 subjects at 30 days.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "142"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "30"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "66"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "43"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "3"}]}]}]}, {"type": "SECONDARY", "title": "Quality of Life (QOL) (COAPT CAS Study Analysis) Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self administered instrument that quantifies physicalfunction, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possiblesubscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies thefollowing six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical FunctionDomain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQSymptom Stability Domain, Clinical Summary Score and Overall Summary Score. Clinical Summary Scoreincludes total symptom and physical function scores to correspond with NYHA Classification. Overall SummaryScore includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. Data was available for 93 subjects at 12 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ Score on a points scale", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "65.93", "spread": "23.80"}]}]}]}, {"type": "SECONDARY", "title": "Quality of Life (QOL) (COAPT CAS Study Analysis) Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score. Clinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification. Overall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. Data was available for 143 subjects at 30 days.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "143"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "61.36", "spread": "25.00"}]}]}]}, {"type": "SECONDARY", "title": "Six Minute Walk Test (6MWT Distance or 6MWD) (COAPT CAS Study Analysis)", "description": "The Six Minute Walk Test (6MWT) is a practical simple test that requires a 100-ft hallway but no exerciseequipment or advanced training for technicians. This test measures the distance that a patient can quickly walk ona flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of allthe systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation,peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific informationon the function of each of the different organs and systems involved in exercise or the mechanism of exerciselimitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses thesubmaximal level of functional capacity.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. 6MWT data was available for 72 subjects at 12 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "72"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "219.87", "spread": "124.82"}]}]}]}, {"type": "SECONDARY", "title": "Six Minute Walk Test (6MWT Distance or 6MWD) (COAPT CAS Study Analysis)", "description": "The Six Minute Walk Test (6MWT) is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific information on the function of each of the different organs and systems involved in exercise or the mechanism of exercise limitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses the submaximal level of functional capacity.", "populationDescription": "A total of 162 subjects were enrolled in the COAPT CAS study. 6MWT data was available for 117 subjects at 30 days..", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "117"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "231.24", "spread": "145.98"}]}]}]}, {"type": "SECONDARY", "title": "Mitral Regurgitation (MR) Severity (COAPT CAS Study Analysis)", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 98 subjects at 12 months.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "98"}]}], "classes": [{"categories": [{"title": "None or Trace/Trivial", "measurements": [{"groupId": "OG000", "value": "9"}]}, {"title": "Mild (1+)", "measurements": [{"groupId": "OG000", "value": "53"}]}, {"title": "Moderate (2+)", "measurements": [{"groupId": "OG000", "value": "27"}]}, {"title": "Moderate - Severe (3+)", "measurements": [{"groupId": "OG000", "value": "6"}]}, {"title": "Severe (4+)", "measurements": [{"groupId": "OG000", "value": "3"}]}]}]}, {"type": "SECONDARY", "title": "Mitral Regurgitation (MR) Severity (COAPT CAS Study Analysis)", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 149 subjects at 30 days.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "149"}]}], "classes": [{"categories": [{"title": "None or Trace/Trivial", "measurements": [{"groupId": "OG000", "value": "11"}]}, {"title": "Mild (1+)", "measurements": [{"groupId": "OG000", "value": "85"}]}, {"title": "Moderate (2+)", "measurements": [{"groupId": "OG000", "value": "40"}]}, {"title": "Moderate - Severe (3+)", "measurements": [{"groupId": "OG000", "value": "9"}]}, {"title": "Severe (4+)", "measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Major and/or Life Threatening Bleeding (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Major and/or Life Threatening Bleeding (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Major Vascular Complications (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Major Vascular Complications (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Renal Complication With Requirement for Dialysis (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Renal Complication With Requirement for Dialysis (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}]}, {"type": "SECONDARY", "title": "Transient Ischemic Attack (TIA) (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Transient Ischemic Attack (TIA) (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"title": "Cardiac", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}]}]}, {"title": "Neurologic", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Renal", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Vascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Infection", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Valvular", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Unknown", "categories": [{"measurements": [{"groupId": "OG000", "value": "24"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Not Available", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "162"}]}], "classes": [{"title": "Cardiac", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Neurologic", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Renal", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Vascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Infection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Valvular", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Unknown", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Patients Free From the Composite of All-cause Death, Stroke, MI, or Non-elective Cardiovascular Surgery for Device Related Complications in the Device Group", "description": "The percentage of patients free from the composite endpoint as described above.", "populationDescription": "All device subjects", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of Participants", "timeFrame": "30 days post-procedure in the Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "96.9", "lowerLimit": "94.7", "upperLimit": "96.9"}]}]}]}, {"type": "SECONDARY", "title": "Number of Deaths at 12 Months (All Cause Mortality)", "description": "Death from any cause mortality at 12months.", "populationDescription": "All device and control group subjects were included in the analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "70"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Mitral Regurgitation Severity Grade of 2+ or Lower at 12 Months", "description": "MR severity grade of 2+ or lower at 12 months MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiography data was available for 210 subjects in Device group and 175 subjects in Control group", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "210"}, {"groupId": "OG001", "value": "175"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "199"}, {"groupId": "OG001", "value": "82"}]}]}]}, {"type": "SECONDARY", "title": "Change in Distance Walked on the 6 Minute Walk Test (6MWT Distance or 6MWD)", "description": "The 6MWT is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD). It evaluates the global and integrated responses of all the systems involved during exercise, including the pulmonary and cardiovascular systems, systemic circulation, peripheral circulation, blood, neuromuscular units, and muscle metabolism. It does not provide specific information on the function of each of the different organs and systems involved in exercise or the mechanism of exercise limitation, as is possible with maximal cardiopulmonary exercise testing. The self-paced 6MWT assesses the submaximal level of functional capacity.", "populationDescription": "Analysis population includes subjects still active and with paired available compared to baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "12 months over baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "230"}, {"groupId": "OG001", "value": "237"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.17", "spread": "9.12"}, {"groupId": "OG001", "value": "-60.2", "spread": "8.99"}]}]}]}, {"type": "SECONDARY", "title": "Change in Quality of Life (QoL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 12 month KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "Analysis population includes subjects still active and with paired available compared to baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ Score on a points scale", "timeFrame": "12 months over baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}, {"groupId": "OG001", "value": "228"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.5", "spread": "1.8"}, {"groupId": "OG001", "value": "-3.6", "spread": "1.9"}]}]}]}, {"type": "SECONDARY", "title": "Change in Left Ventricular End Diastolic Volume (LVEDV)", "description": "Paired data comparing the Change in LVEDV at baseline vs 12 months", "populationDescription": "Analysis population includes subjects with echocardiography paired data available", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "12 months over baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "175"}, {"groupId": "OG001", "value": "174"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-3.71", "spread": "5.08"}, {"groupId": "OG001", "value": "17.06", "spread": "5.10"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With New York Heart Association (NYHA) Functional Class I/II", "description": "NEW YORK HEART ASSOCIATION CLASSIFICATION (NYHA CLASS)\n\nClass I: Patients with cardiac disease but without resulting limitations of physical activity.\n\nClass II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.\n\nClass III: Patients with cardiac disease resulting in marked limitation of physical activity. Patients are comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation dyspnea, or anginal pain.\n\nClass IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or of the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.", "populationDescription": "Analysis population includes subjects with available NYHA class data at 12 months", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}, {"groupId": "OG001", "value": "232"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "171"}, {"groupId": "OG001", "value": "115"}]}]}]}, {"type": "SECONDARY", "title": "Recurrent Hospitalizations - All Cause", "description": "Number of Recurrent Hospitalizations for any cause within 24 months.", "populationDescription": "All randomized subjects in Device and Control Group", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Number of Events", "timeFrame": "24 Months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "474"}, {"groupId": "OG001", "value": "610"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.02", "statisticalMethod": "Joint Fraility Model", "paramType": "Hazard Ratio (HR)", "paramValue": "0.76", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.60", "ciUpperLimit": "0.96"}]}, {"type": "SECONDARY", "title": "Death or HF Hospitalization Within 24 Months (Finkelstein-Schoenfeld Analysis of All-Cause Death or Recurrent HF Hospitalization Through 24 Months)", "description": "The win ratio is a useful method for providing an estimate of the treatment effect when composite endpoints are analyzed as the analysis accounts for clinical significance of the outcomes of interest. For example, in the composite of death and recurrent HF hospitalizations through 24 months, subjects in the Device and Control groups were formed into matched pairs, where each pair of subjects was classified into 1 of 5 outcomes scenarios:\n\nA. Death in Device group first B. Death in Control group first C. More HF hospitalizations in the Device group (or in the case of a tie, the first HF hospitalization in the Device group occurs first) D. More HF hospitalization in the Control group (or in the case of tie, the first HF hospitalization in the Control group occurs first) E. None of the above In this way, the number of \"Winners\" in the Device group was NW = NB + ND while the number of \"Losers\" in the Device group was NL = NA + NC. The \"Win Ratio\" was then calculated as NW/NL.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Win Ratio", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "Randomized Group", "description": "Randomized group contains both Device and Control Group"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "614"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.61", "lowerLimit": "1.29", "upperLimit": "2.04"}]}]}], "analyses": [{"groupIds": ["OG000"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.0001", "statisticalMethod": "Finkelstein-Schoenfeld Analysis", "paramType": "Win Ratio", "paramValue": "1.61", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.29", "ciUpperLimit": "2.04"}]}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "description": "The COAPT study is still on-going. Only the Primary and major secondary endpoints have been entered. Rest of the results will be entered when the study ends in July 2024.", "reportingStatus": "NOT_POSTED", "anticipatedPostingDate": "2024-07", "timeFrame": "2 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "3 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "4 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Death and Primary Cause of Death (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "5 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "3 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "4 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Myocardial Infarction (MI) (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "5 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "3 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "4 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Stroke (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "5 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "3 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "4 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Recurrent Heart Failure (HF) Hospitalization (COAPT CAS Study Analysis)", "reportingStatus": "NOT_POSTED", "timeFrame": "5 years", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Death from any cause within 24 months - no of events", "populationDescription": "Total number of subjects randomized in the Device and Control group", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "no of events", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "125"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Device or Procedure-Related Adverse Events", "description": "Device or procedure-related adverse events are defined as adverse events that are adjudicated by the Clinical Events Committee as possibly, probably or definitely device and/or procedure-related, regardless of the temporal relationship to the MitraClip procedure. Device or procedure-related adverse events will be broken down into those that occur within 30 days of the procedure and those that occur after 30 days of the procedure. Examples of device-related adverse events are: myocardial perforation, Single Leaflet Device Attachment, embolization of the MitraClip device or MitraClip System components, iatrogenic atrial septal defect, mitral valve stenosis, need for mitral valve replacement instead of repair due at least in part to the MitraClip procedure or the presence of the MitraClip device.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Within and after 30 days of the procedure", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}]}], "classes": [{"title": "Occurred within 30 days", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}]}]}, {"title": "Occurred between 31 days and 365 days", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Implant Rate", "description": "Defined as the rate of successful delivery and deployment of the MitraClip device(s) with echocardiographic evidence of leaflet approximation and retrieval of the delivery catheter", "populationDescription": "Subjects randomized to the device arm", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "287"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Device Procedure Time", "description": "Defined as the time elapsed from the start of the transseptal procedure to the time the Steerable Guide Catheter is removed", "populationDescription": "Device procedure time was not available for all implanted subjects. Data was available for 282 subjects from 302 randomized subjects in device arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "minutes", "timeFrame": "Day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "282"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "118.9", "spread": "63.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Total Procedure Time", "description": "Defined as the time elapsed from the first of any of the following: intravascular catheter placement, anesthesia or sedation, or transesophageal echocardiogram (TEE), to the removal of the last catheter and TEE", "populationDescription": "Total procedure time was available for 293 subjects from the 302 subjects randomized to device arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "minutes", "timeFrame": "Day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "293"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "162.9", "spread": "118.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Device Time", "description": "Defined as the time the Steerable Guide Catheter is placed in the intra-atrial septum until the time the MitraClip Delivery System (CDS) is retracted into the Steerable Guide Catheter", "populationDescription": "Device time available for all 287 subjects implanted with MitraClip.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "minutes", "timeFrame": "Day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "287"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "82.7", "spread": "80.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Fluoroscopy Duration", "description": "Defined as the duration of exposure to fluoroscopy during the MitraClip procedure", "populationDescription": "Fluoroscopy duration for all available subjects with MitraClip device", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "minutes", "timeFrame": "Day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "284"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "33.9", "spread": "23.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "echocardiogram data was available for 302 subjects in the device arm and 311 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "classes": [{"categories": [{"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "172"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "154"}, {"groupId": "OG001", "value": "139"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 286 subjects in the device arm and 257 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "286"}, {"groupId": "OG001", "value": "257"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "230"}, {"groupId": "OG001", "value": "21"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "67"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "96"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "73"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for only 240 subjects in the device group and 218 subjects in the control group", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "240"}, {"groupId": "OG001", "value": "218"}]}], "classes": [{"categories": [{"title": "MR none or 1+", "measurements": [{"groupId": "OG000", "value": "160"}, {"groupId": "OG001", "value": "20"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "65"}, {"groupId": "OG001", "value": "63"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "92"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "43"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 210 subjects in the device arm and 175 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "210"}, {"groupId": "OG001", "value": "175"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "145"}, {"groupId": "OG001", "value": "20"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "54"}, {"groupId": "OG001", "value": "62"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "60"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "33"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below\n\nMR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 167 subjects in the device arm and 126 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "167"}, {"groupId": "OG001", "value": "126"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "23"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "36"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "43"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "24"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR3+ - Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 120 subjects in the device arm and 74 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "120"}, {"groupId": "OG001", "value": "74"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "100"}, {"groupId": "OG001", "value": "48"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "15"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "8"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography and subjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effective regurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Right ventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ -Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitant orifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricular EF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 80 subjects in the device arm and 49 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}, {"groupId": "OG001", "value": "49"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "64"}, {"groupId": "OG001", "value": "30"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "9"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "MR Severity Grade", "description": "MR Severity Grading was done by Quantitative Doppler Echocardiography andsubjects were graded as below MR 1+ - Regurgitant Volume \\< 30 ml, Right ventricular EF \\<30%, Effectiveregurgitant orifice area \\< 20 mm\\^2 MR 2+ - Regurgitant Volume 30-44 ml, Rightventricular EF 30-39%, Effective regurgitant orifice area 20-29 mm\\^2 MR 3+ -Regurgitant Volume 45-59 ml, Right ventricular EF 40-49 %, Effective regurgitantorifice area 30-39 mm\\^2 MR 4+ - Regurgitant Volume \\>= 60 ml, Right ventricularEF \\>=50%, Effective regurgitant orifice area \\>=40 mm\\^2", "populationDescription": "Echocardiogram data was available for 57 subjects in the device arm and 46 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "46"}]}], "classes": [{"categories": [{"title": "MR None or 1+", "measurements": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "36"}]}, {"title": "MR 2+", "measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}]}, {"title": "MR 3+", "measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}]}, {"title": "MR 4+", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for the 289 subjects in the device arm and 302 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "289"}, {"groupId": "OG001", "value": "302"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.41", "spread": "0.15"}, {"groupId": "OG001", "value": "0.40", "spread": "0.15"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for 75 subjects in the device arm and 73 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "73"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.14", "spread": "0.08"}, {"groupId": "OG001", "value": "0.23", "spread": "0.16"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for 39 subjects in the device arm and 54 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "54"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.22", "spread": "0.19"}, {"groupId": "OG001", "value": "0.25", "spread": "0.14"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for 39 subjects in the device arm and 46 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "46"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.12"}, {"groupId": "OG001", "value": "0.26", "spread": "0.19"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for 18 subjects in the device arm and 25 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.09"}, {"groupId": "OG001", "value": "0.25", "spread": "0.12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for 16 subjects in the device arm and 13 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "13"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.20"}, {"groupId": "OG001", "value": "0.18", "spread": "0.10"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for the 8 subjects in the device arm and 6 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.14", "spread": "0.05"}, {"groupId": "OG001", "value": "0.19", "spread": "0.12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Effective Regurgitant Orifice Area", "description": "Effective Regurgitant Orifice area is defined as = Regurgitant flow / Regurgitant velocity", "populationDescription": "Echocardiogram data was available for the 7 subjects in the device arm and 7 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.05"}, {"groupId": "OG001", "value": "0.15", "spread": "0.05"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 124 subjects in the device arm and 136 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "136"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.80", "spread": "16.99"}, {"groupId": "OG001", "value": "25.01", "spread": "15.31"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 85 subjects in device arm and 70 subjects in control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20.04", "spread": "11.86"}, {"groupId": "OG001", "value": "25.97", "spread": "15.68"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 45 subjects in the device arm and 54 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "54"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23.60", "spread": "16.00"}, {"groupId": "OG001", "value": "32.59", "spread": "15.82"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 33 subjects in the device arm and 45 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "45"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.61", "spread": "12.12"}, {"groupId": "OG001", "value": "27.76", "spread": "14.35"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 21 subjects in the device arm and 28 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.48", "spread": "11.34"}, {"groupId": "OG001", "value": "32.96", "spread": "16.04"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from theLeft Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 20 subjects in the device arm and 17 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "17"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18.80", "spread": "9.61"}, {"groupId": "OG001", "value": "24.65", "spread": "12.26"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 11 subjects in the device arm and 5 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18.36", "spread": "6.27"}, {"groupId": "OG001", "value": "23.00", "spread": "14.47"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Volume", "description": "Regurgitant Volume is calculated by subtracting the inflow volume across the mitral valve during diastole from the Left Ventricular Outflow Tract (LVOT) stroke volume during systole.", "populationDescription": "Echocardiogram data was available for 9 subjects in the device arm and 9 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/beat", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "9"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.11", "spread": "10.11"}, {"groupId": "OG001", "value": "18.78", "spread": "5.95"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data was available for 123 subjects in the device group and 136 subjects in the control group.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "123"}, {"groupId": "OG001", "value": "136"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "38.24", "spread": "13.81"}, {"groupId": "OG001", "value": "34.81", "spread": "14.94"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data was available for 85 subjects in the device arm and 70 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31.00", "spread": "14.53"}, {"groupId": "OG001", "value": "35.29", "spread": "15.32"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data was available for 45 subjects in the device arm and 54 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "54"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "34.14", "spread": "15.89"}, {"groupId": "OG001", "value": "42.20", "spread": "14.49"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data was available for 33 subjects in the device arm and 45 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "45"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "32.15", "spread": "13.06"}, {"groupId": "OG001", "value": "37.80", "spread": "15.49"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data is available for 21 subjects in the device arm and 28 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "34.29", "spread": "14.52"}, {"groupId": "OG001", "value": "41.79", "spread": "14.93"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricledue to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data is available for 20 subjects in the device arm and 17 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "17"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31.00", "spread": "12.38"}, {"groupId": "OG001", "value": "38.71", "spread": "10.21"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency.", "populationDescription": "Echocardiogram data was available for 11 subjects in the device arm and 5 subjects in the control arm", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "32.00", "spread": "7.72"}, {"groupId": "OG001", "value": "38.80", "spread": "21.51"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Regurgitant Fraction", "description": "Regurgitant fraction is the percentage of blood that regurgitates back through the aortic valve to the left ventricle due to aortic insufficiency, or through the mitral valve to the atrium due to mitral insufficiency", "populationDescription": "Echocardiogram data is available for 9 subjects in the device arm and 9 subjects in the control arm.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "9"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.78", "spread": "12.77"}, {"groupId": "OG001", "value": "32.78", "spread": "9.20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data used for analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "294"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "194.4", "spread": "69.2"}, {"groupId": "OG001", "value": "191.0", "spread": "72.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "259"}, {"groupId": "OG001", "value": "223"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "176.0", "spread": "64.6"}, {"groupId": "OG001", "value": "179.1", "spread": "68.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}, {"groupId": "OG001", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "181.4", "spread": "65.1"}, {"groupId": "OG001", "value": "182.6", "spread": "72.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}, {"groupId": "OG001", "value": "146"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "179.4", "spread": "66.2"}, {"groupId": "OG001", "value": "176.3", "spread": "65.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "121"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "174.5", "spread": "60.9"}, {"groupId": "OG001", "value": "184.6", "spread": "73.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "51"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "169.6", "spread": "60.5"}, {"groupId": "OG001", "value": "172.2", "spread": "67.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available electrocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "166.0", "spread": "58.4"}, {"groupId": "OG001", "value": "161.6", "spread": "64.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricle End Diastolic Volume (LVEDV)", "description": "Left Ventricle End-diastolic volume is the amount of blood that is in the left ventricle before the heart contracts.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "32"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "174.0", "spread": "67.1"}, {"groupId": "OG001", "value": "166.6", "spread": "77.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "294"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "135.5", "spread": "56.1"}, {"groupId": "OG001", "value": "134.3", "spread": "60.3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}, {"groupId": "OG001", "value": "223"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "129.3", "spread": "56.5"}, {"groupId": "OG001", "value": "125.7", "spread": "57.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}, {"groupId": "OG001", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "133.1", "spread": "59.2"}, {"groupId": "OG001", "value": "129.1", "spread": "59.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}, {"groupId": "OG001", "value": "146"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "133.0", "spread": "60.9"}, {"groupId": "OG001", "value": "125.9", "spread": "54.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "121"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "127.4", "spread": "52.6"}, {"groupId": "OG001", "value": "132.2", "spread": "64.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction,or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at anypoint in the cardiac cycle.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "51"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "124.3", "spread": "58.3"}, {"groupId": "OG001", "value": "122.9", "spread": "61.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available electrocardiogram has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "118.7", "spread": "53.1"}, {"groupId": "OG001", "value": "112.7", "spread": "59.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Volume (LVESV)", "description": "Left Ventricular End-systolic volume (LVESV) is the volume of blood in the left ventricle at the end of contraction, or systole, and the beginning of filling, or diastole. LVESV is the lowest volume of blood in the left ventricle at any point in the cardiac cycle.", "populationDescription": "All available electrocardiogram has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "32"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "129.0", "spread": "65.4"}, {"groupId": "OG001", "value": "119.3", "spread": "70.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "301"}, {"groupId": "OG001", "value": "307"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.17", "spread": "0.73"}, {"groupId": "OG001", "value": "6.19", "spread": "0.75"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "286"}, {"groupId": "OG001", "value": "249"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.10", "spread": "0.75"}, {"groupId": "OG001", "value": "7.41", "spread": "19.58"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "231"}, {"groupId": "OG001", "value": "210"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.12", "spread": "0.77"}, {"groupId": "OG001", "value": "6.15", "spread": "0.81"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "198"}, {"groupId": "OG001", "value": "174"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.08", "spread": "0.77"}, {"groupId": "OG001", "value": "6.10", "spread": "0.83"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "157"}, {"groupId": "OG001", "value": "126"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.07", "spread": "0.92"}, {"groupId": "OG001", "value": "6.18", "spread": "0.88"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All Available echocardiogram data has been entered", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "115"}, {"groupId": "OG001", "value": "77"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.12", "spread": "0.78"}, {"groupId": "OG001", "value": "6.11", "spread": "0.97"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "78"}, {"groupId": "OG001", "value": "49"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.04", "spread": "0.81"}, {"groupId": "OG001", "value": "6.07", "spread": "0.91"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Diastolic Dimension (LVEDD)", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "45"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.09", "spread": "0.90"}, {"groupId": "OG001", "value": "5.97", "spread": "0.91"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "301"}, {"groupId": "OG001", "value": "306"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.28", "spread": "0.86"}, {"groupId": "OG001", "value": "5.30", "spread": "0.89"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "286"}, {"groupId": "OG001", "value": "248"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.31", "spread": "0.89"}, {"groupId": "OG001", "value": "6.12", "spread": "12.64"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "231"}, {"groupId": "OG001", "value": "208"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.34", "spread": "0.91"}, {"groupId": "OG001", "value": "5.28", "spread": "0.96"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "197"}, {"groupId": "OG001", "value": "173"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.26", "spread": "0.95"}, {"groupId": "OG001", "value": "5.25", "spread": "0.99"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "156"}, {"groupId": "OG001", "value": "123"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.24", "spread": "1.07"}, {"groupId": "OG001", "value": "5.26", "spread": "1.02"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "112"}, {"groupId": "OG001", "value": "75"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.30", "spread": "0.96"}, {"groupId": "OG001", "value": "5.19", "spread": "1.16"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "47"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.17", "spread": "0.95"}, {"groupId": "OG001", "value": "5.01", "spread": "1.12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular End Systolic Dimension (LVESD)", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "54"}, {"groupId": "OG001", "value": "42"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.31", "spread": "1.02"}, {"groupId": "OG001", "value": "5.15", "spread": "1.02"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "294"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31.32", "spread": "9.07"}, {"groupId": "OG001", "value": "31.30", "spread": "9.58"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "259"}, {"groupId": "OG001", "value": "223"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27.88", "spread": "8.84"}, {"groupId": "OG001", "value": "31.11", "spread": "10.45"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}, {"groupId": "OG001", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.38", "spread": "10.45"}, {"groupId": "OG001", "value": "30.44", "spread": "10.15"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}, {"groupId": "OG001", "value": "146"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27.74", "spread": "11.31"}, {"groupId": "OG001", "value": "29.72", "spread": "10.06"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "121"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27.95", "spread": "9.2"}, {"groupId": "OG001", "value": "30.68", "spread": "12.38"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "51"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "29.28", "spread": "12.41"}, {"groupId": "OG001", "value": "31.67", "spread": "12.76"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All available electrocardiogram has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "30.87", "spread": "11.37"}, {"groupId": "OG001", "value": "33.39", "spread": "13.09"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Left Ventricular Ejection Fraction (LVEF)", "populationDescription": "All electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "32"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.73", "spread": "11.26"}, {"groupId": "OG001", "value": "32.22", "spread": "13.95"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "275"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "43.95", "spread": "13.44"}, {"groupId": "OG001", "value": "44.56", "spread": "13.96"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "257"}, {"groupId": "OG001", "value": "239"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "41.41", "spread": "11.63"}, {"groupId": "OG001", "value": "43.81", "spread": "14.24"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "196"}, {"groupId": "OG001", "value": "188"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "40.96", "spread": "13.06"}, {"groupId": "OG001", "value": "42.21", "spread": "14.19"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "170"}, {"groupId": "OG001", "value": "144"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "38.63", "spread": "13.00"}, {"groupId": "OG001", "value": "39.31", "spread": "13.24"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}, {"groupId": "OG001", "value": "100"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "39.46", "spread": "12.90"}, {"groupId": "OG001", "value": "40.27", "spread": "14.92"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "100"}, {"groupId": "OG001", "value": "60"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.73", "spread": "11.56"}, {"groupId": "OG001", "value": "37.57", "spread": "13.61"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "65"}, {"groupId": "OG001", "value": "38"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.37", "spread": "13.04"}, {"groupId": "OG001", "value": "39.76", "spread": "14.54"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Right Ventricular Systolic Pressure (RVSP)", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "32"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "34.85", "spread": "12.92"}, {"groupId": "OG001", "value": "35.41", "spread": "12.12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "284"}, {"groupId": "OG001", "value": "302"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.17", "spread": "1.26"}, {"groupId": "OG001", "value": "5.16", "spread": "1.16"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "174"}, {"groupId": "OG001", "value": "235"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.68", "spread": "0.92"}, {"groupId": "OG001", "value": "4.81", "spread": "1.00"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "107"}, {"groupId": "OG001", "value": "189"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.84", "spread": "1.10"}, {"groupId": "OG001", "value": "4.94", "spread": "1.00"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}, {"groupId": "OG001", "value": "142"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.67", "spread": "0.86"}, {"groupId": "OG001", "value": "4.88", "spread": "0.95"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "65"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.85", "spread": "1.01"}, {"groupId": "OG001", "value": "4.98", "spread": "1.14"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "39"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.06", "spread": "0.90"}, {"groupId": "OG001", "value": "4.47", "spread": "1.58"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.27", "spread": "0.79"}, {"groupId": "OG001", "value": "4.39", "spread": "1.41"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Area", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.76", "spread": "1.11"}, {"groupId": "OG001", "value": "4.33", "spread": "1.31"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "208"}, {"groupId": "OG001", "value": "234"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.46", "spread": "1.05"}, {"groupId": "OG001", "value": "2.28", "spread": "0.97"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "282"}, {"groupId": "OG001", "value": "184"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.10", "spread": "2.18"}, {"groupId": "OG001", "value": "2.28", "spread": "1.28"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "222"}, {"groupId": "OG001", "value": "160"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.00", "spread": "1.98"}, {"groupId": "OG001", "value": "2.28", "spread": "1.28"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "197"}, {"groupId": "OG001", "value": "138"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.88", "spread": "2.17"}, {"groupId": "OG001", "value": "2.15", "spread": "1.30"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "151"}, {"groupId": "OG001", "value": "96"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.69", "spread": "1.76"}, {"groupId": "OG001", "value": "2.25", "spread": "1.71"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, thevalve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valvegradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "111"}, {"groupId": "OG001", "value": "63"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.45", "spread": "1.80"}, {"groupId": "OG001", "value": "2.62", "spread": "1.99"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.69", "spread": "1.85"}, {"groupId": "OG001", "value": "2.56", "spread": "1.41"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mean Mitral Valve Gradient", "description": "The normal area of the mitral valve orifice is about 4-6 cm2 when the mitral valve area goes below 2 cm2, the valve causes an impediment to the flow of blood into the left ventricle, creating a pressure gradient (mitral valve gradient) across the mitral valve. This gradient may increase by the rise in heart rate or cardiac output.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "37"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.07", "spread": "2.31"}, {"groupId": "OG001", "value": "3.54", "spread": "4.27"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "300"}, {"groupId": "OG001", "value": "310"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "299"}, {"groupId": "OG001", "value": "309"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "289"}, {"groupId": "OG001", "value": "258"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "288"}, {"groupId": "OG001", "value": "257"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "239"}, {"groupId": "OG001", "value": "219"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "239"}, {"groupId": "OG001", "value": "218"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available echocardiogram has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "210"}, {"groupId": "OG001", "value": "177"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "210"}, {"groupId": "OG001", "value": "177"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "126"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "126"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "120"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "120"}, {"groupId": "OG001", "value": "78"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "81"}, {"groupId": "OG001", "value": "50"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "81"}, {"groupId": "OG001", "value": "50"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Systolic Anterior Motion of the Mitral Valve (Present or Absent)", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "58"}, {"groupId": "OG001", "value": "46"}]}], "classes": [{"categories": [{"title": "Present", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Absent", "measurements": [{"groupId": "OG000", "value": "58"}, {"groupId": "OG001", "value": "46"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/minute", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "238"}, {"groupId": "OG001", "value": "251"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.61", "spread": "1.09"}, {"groupId": "OG001", "value": "3.49", "spread": "1.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/minute", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "275"}, {"groupId": "OG001", "value": "236"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.79", "spread": "1.17"}, {"groupId": "OG001", "value": "3.61", "spread": "1.18"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available echocardiogram has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/minute", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "217"}, {"groupId": "OG001", "value": "199"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.53", "spread": "1.06"}, {"groupId": "OG001", "value": "3.53", "spread": "1.16"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/minute", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "196"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.59", "spread": "1.07"}, {"groupId": "OG001", "value": "3.66", "spread": "1.20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/minute", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "144"}, {"groupId": "OG001", "value": "116"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.41", "spread": "0.96"}, {"groupId": "OG001", "value": "3.38", "spread": "1.01"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available data has been entered.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "L/min", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "110"}, {"groupId": "OG001", "value": "68"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.39", "spread": "1.01"}, {"groupId": "OG001", "value": "3.36", "spread": "1.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters/minute", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "46"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.49", "spread": "0.99"}, {"groupId": "OG001", "value": "3.42", "spread": "1.27"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiac Output", "description": "The amount of blood the heart pumps through the circulatory system in a minute.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters/minute", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "38"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.43", "spread": "1.02"}, {"groupId": "OG001", "value": "3.41", "spread": "1.10"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "283"}, {"groupId": "OG001", "value": "292"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "50.47", "spread": "16.52"}, {"groupId": "OG001", "value": "50.72", "spread": "16.91"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "At discharge (or 30 days if discharge echocardiogram is not available)", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "278"}, {"groupId": "OG001", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "52.41", "spread": "17.06"}, {"groupId": "OG001", "value": "50.75", "spread": "17.69"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "222"}, {"groupId": "OG001", "value": "207"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "52.13", "spread": "16.60"}, {"groupId": "OG001", "value": "49.89", "spread": "16.80"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}, {"groupId": "OG001", "value": "165"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "52.33", "spread": "16.46"}, {"groupId": "OG001", "value": "53.49", "spread": "17.73"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "147"}, {"groupId": "OG001", "value": "118"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "50.23", "spread": "16.02"}, {"groupId": "OG001", "value": "49.22", "spread": "15.70"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "111"}, {"groupId": "OG001", "value": "68"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "49.19", "spread": "15.83"}, {"groupId": "OG001", "value": "49.42", "spread": "15.29"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "50.95", "spread": "16.46"}, {"groupId": "OG001", "value": "48.32", "spread": "14.36"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Forward Stroke Volume", "description": "Stroke volume is the amount of blood ejected from the ventricle with each cardiac cycle. It can be readily calculated by subtracting the end-systolic volume from the end-diastolic volume.", "populationDescription": "All available electrocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "38"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "49.70", "spread": "18.41"}, {"groupId": "OG001", "value": "47.63", "spread": "16.75"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All eligible subjects with MitraClip until the 365 day window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "12 months in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}]}], "classes": [{"title": "Single Leaflet Device Attachment (SLDA)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "236"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.3"}]}]}, {"title": "Embolization", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}, {"title": "Left Ventricular Assist Device (LVAD)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "235"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "98.8"}]}]}, {"title": "Heart Transplant", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "235"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.2"}]}]}, {"title": "Non-elective Cardiovascular surgery", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available subjects with data within the 2 year (731 days) window", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "24 months in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}]}], "classes": [{"title": "Single Leaflet Device Attachment (SLDA)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.3"}]}]}, {"title": "Embolization", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}, {"title": "Left Ventricular Assist Device (LVAD)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "201"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "97.4"}]}]}, {"title": "Heart Transplant", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "201"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "98.7"}]}]}, {"title": "Non-elective cardiovascular surgery", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available subjects within the 36 month (1096 days) window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage", "timeFrame": "3 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}]}], "classes": [{"title": "Single Leaflet DeviceAttachment (SLDA)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.3"}]}]}, {"title": "Embolization", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}, {"title": "Left Ventricular AssistDevice (LVAD)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "159"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "94.9"}]}]}, {"title": "Heart Transplant", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "158"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "96.6"}]}]}, {"title": "Non-electivecardiovascular surgery", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device relatedcomplications including Single Leaflet Device Attachment (SLDA), deviceembolizations, endocarditis requiring surgery, Echocardiography Core Laboratoryconfirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at12 months will be the primary measure of safety.", "populationDescription": "All subjects within the 4 year (1461 days) window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "4 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}]}], "classes": [{"title": "Single Leaflet Device Attachment (SLDA)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.3"}]}]}, {"title": "Embolization", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}, {"title": "Left Ventricular Assist Device (LVAD)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "134"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "94.2"}]}]}, {"title": "Heart Transplant", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "95.3"}]}]}, {"title": "Non-elective Cardiovascular Surgery", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Components of the Primary Safety Composite", "description": "Freedom from the components of the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at12 months will be the primary measure of safety.", "populationDescription": "All available subjects within 5 year (1826 days) window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "5 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "classes": [{"title": "Single LeafletDeviceAttachment(SLDA)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.3"}]}]}, {"title": "Embolization", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}, {"title": "Left VentricularAssistDevice (LVAD)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "93.5"}]}]}, {"title": "Heart Transplant", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "65"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "95.3"}]}]}, {"title": "Non-electivecardiovascularsurgery", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "99.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available subjects with data within the 24 months (731 days) window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "24 months in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "197"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "94.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet DeviceAttachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratoryconfirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complicationsrequiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available subjects with data within the 36 months (1096 days) window.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage", "timeFrame": "3 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "154"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "91.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available echocardiogram data has been presented.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "4 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "89.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the Primary Safety Composite", "description": "Freedom from the primary safety composite of device related complications including Single Leaflet Device Attachment (SLDA), device embolizations, endocarditis requiring surgery, Echocardiography Core Laboratory confirmed mitral stenosis requiring surgery, LVAD implant, heart transplant, or any device related complications requiring non-elective cardiovascular surgery at 12 months will be the primary measure of safety.", "populationDescription": "All available electrocardiogram has been presented.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage", "timeFrame": "5 years in Device group", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "62"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "89.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 24 months", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "205"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "71.9", "lowerLimit": "66.4", "upperLimit": "76.6"}, {"groupId": "OG001", "value": "57.3", "lowerLimit": "51.4", "upperLimit": "62.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 36 months", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "167"}, {"groupId": "OG001", "value": "122"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "59.7", "lowerLimit": "53.8", "upperLimit": "65.1"}, {"groupId": "OG001", "value": "45.9", "lowerLimit": "40.0", "upperLimit": "51.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 48 months", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "51.3", "lowerLimit": "45.4", "upperLimit": "57.0"}, {"groupId": "OG001", "value": "37.3", "lowerLimit": "31.6", "upperLimit": "43.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From All-cause Mortality", "description": "Kaplan-Meier survival rate for all cause mortality at 60 months", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "79"}, {"groupId": "OG001", "value": "59"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "42.7", "lowerLimit": "36.8", "upperLimit": "48.5"}, {"groupId": "OG001", "value": "32.8", "lowerLimit": "27.2", "upperLimit": "38.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "238"}, {"groupId": "OG001", "value": "223"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "86.2", "lowerLimit": "81.6", "upperLimit": "89.7"}, {"groupId": "OG001", "value": "80.7", "lowerLimit": "75.7", "upperLimit": "84.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "205"}, {"groupId": "OG001", "value": "156"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "77.6", "lowerLimit": "72.3", "upperLimit": "82.1"}, {"groupId": "OG001", "value": "64.5", "lowerLimit": "58.6", "upperLimit": "69.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From Cardiovascular Mortality", "description": "Kaplan-Meier survival rate for Cardiovascular mortality.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "167"}, {"groupId": "OG001", "value": "120"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "66.7", "lowerLimit": "60.7", "upperLimit": "72.0"}, {"groupId": "OG001", "value": "54.6", "lowerLimit": "48.3", "upperLimit": "60.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From Cardiovascular Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}, {"groupId": "OG001", "value": "94"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "58.8", "lowerLimit": "52.6", "upperLimit": "64.5"}, {"groupId": "OG001", "value": "47.0", "lowerLimit": "40.6", "upperLimit": "53.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From Cardiovascular Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "79"}, {"groupId": "OG001", "value": "59"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "51.2", "lowerLimit": "44.8", "upperLimit": "57.2"}, {"groupId": "OG001", "value": "42.8", "lowerLimit": "36.4", "upperLimit": "49.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "194"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "74.4", "lowerLimit": "68.9", "upperLimit": "79.1"}, {"groupId": "OG001", "value": "60.4", "lowerLimit": "54.5", "upperLimit": "65.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "158"}, {"groupId": "OG001", "value": "95"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "64.5", "lowerLimit": "58.5", "upperLimit": "69.9"}, {"groupId": "OG001", "value": "43.9", "lowerLimit": "37.9", "upperLimit": "49.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "118"}, {"groupId": "OG001", "value": "43"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "53.2", "lowerLimit": "46.9", "upperLimit": "59.2"}, {"groupId": "OG001", "value": "23.6", "lowerLimit": "18.2", "upperLimit": "29.3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "93"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "45.7", "lowerLimit": "39.3", "upperLimit": "51.8"}, {"groupId": "OG001", "value": "22.3", "lowerLimit": "17.0", "upperLimit": "28.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "17"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "39.0", "lowerLimit": "32.6", "upperLimit": "45.4"}, {"groupId": "OG001", "value": "17.0", "lowerLimit": "11.9", "upperLimit": "22.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "166"}, {"groupId": "OG001", "value": "137"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "61.7", "lowerLimit": "55.8", "upperLimit": "67.1"}, {"groupId": "OG001", "value": "51.3", "lowerLimit": "45.5", "upperLimit": "56.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "126"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "49.5", "lowerLimit": "43.5", "upperLimit": "55.2"}, {"groupId": "OG001", "value": "33.5", "lowerLimit": "27.9", "upperLimit": "39.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "87"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.3", "lowerLimit": "31.4", "upperLimit": "43.1"}, {"groupId": "OG001", "value": "17.5", "lowerLimit": "12.9", "upperLimit": "22.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.5", "lowerLimit": "23.0", "upperLimit": "34.2"}, {"groupId": "OG001", "value": "14.8", "lowerLimit": "10.5", "upperLimit": "19.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First Cardiovascular Hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}, {"groupId": "OG001", "value": "11"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23.0", "lowerLimit": "17.9", "upperLimit": "28.6"}, {"groupId": "OG001", "value": "10.8", "lowerLimit": "7.0", "upperLimit": "15.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "196"}, {"groupId": "OG001", "value": "156"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "66.5", "lowerLimit": "60.8", "upperLimit": "71.5"}, {"groupId": "OG001", "value": "53.8", "lowerLimit": "48.1", "upperLimit": "59.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "description": "Survival rate from the first HF related hospitalization or all-cause mortality.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "158"}, {"groupId": "OG001", "value": "95"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "54.8", "lowerLimit": "48.9", "upperLimit": "60.3"}, {"groupId": "OG001", "value": "33.8", "lowerLimit": "28.4", "upperLimit": "39.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "118"}, {"groupId": "OG001", "value": "43"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "41.5", "lowerLimit": "35.8", "upperLimit": "47.1"}, {"groupId": "OG001", "value": "15.5", "lowerLimit": "11.5", "upperLimit": "20.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "93"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "34.0", "lowerLimit": "28.6", "upperLimit": "39.5"}, {"groupId": "OG001", "value": "12.8", "lowerLimit": "9.1", "upperLimit": "17.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kaplan-Meier Freedom From the First HF Related Hospitalization or All-cause Mortality", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "17"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "26.4", "lowerLimit": "21.4", "upperLimit": "31.7"}, {"groupId": "OG001", "value": "8.5", "lowerLimit": "5.5", "upperLimit": "12.3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "populationDescription": "NYHA Class data available for only 311 subjects", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "NYHA Class I", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "NYHA Class II", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "129"}, {"groupId": "OG001", "value": "110"}]}]}, {"title": "NYHA Class III", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "154"}, {"groupId": "OG001", "value": "168"}]}]}, {"title": "NYHA Class IV", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "33"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "populationDescription": "All available data at 30 day follow-up", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "278"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "14"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "172"}, {"groupId": "OG001", "value": "120"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "117"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "27"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "238"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "14"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "139"}, {"groupId": "OG001", "value": "117"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "100"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "191"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "18"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "97"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "42"}, {"groupId": "OG001", "value": "65"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "11"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due to symptoms Class IV: Severe limitations", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "176"}, {"groupId": "OG001", "value": "143"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "12"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "91"}, {"groupId": "OG001", "value": "69"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "54"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "description": "Measure Description: The New York Heart Association (NYHA) Classification provides a simple way of classifyingthe extent of heart failure. It classifies patients in one of four categories based on their limitations during physicalactivity:\n\nClass I: No symptoms and no limitation in ordinary physical activity Class II: Mild symptoms (mild shortness ofbreath and/or angina) and slight limitation during ordinary activity Class III: Marked limitation in activity due tosymptoms Class IV: Severe limitations", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "146"}, {"groupId": "OG001", "value": "102"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "16"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "48"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "32"}, {"groupId": "OG001", "value": "32"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}, {"groupId": "OG001", "value": "76"}]}], "classes": [{"title": "NYHA Class I", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "10"}]}]}, {"title": "NYHA Class II", "categories": [{"measurements": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "36"}]}]}, {"title": "NYHA Class III", "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "25"}]}]}, {"title": "NYHA Class IV", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "NYHA Functional Class", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "65"}]}], "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "12"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "27"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "26"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Six-Minute Walk Test Distance (6MWD)", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "populationDescription": "All available 6MWD has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "296"}, {"groupId": "OG001", "value": "305"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "249.6", "spread": "123.8"}, {"groupId": "OG001", "value": "234.5", "spread": "123.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "265"}, {"groupId": "OG001", "value": "244"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "290.1", "spread": "122.8"}, {"groupId": "OG001", "value": "243.0", "spread": "121.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "populationDescription": "All available 6MWD has been reported", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}, {"groupId": "OG001", "value": "203"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "288.6", "spread": "128.0"}, {"groupId": "OG001", "value": "253.9", "spread": "126.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "populationDescription": "All available 6MWD has been reported", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "193"}, {"groupId": "OG001", "value": "167"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "308.4", "spread": "116.7"}, {"groupId": "OG001", "value": "269.7", "spread": "133.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "6MWD", "description": "Six-Minute Walk Test is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk test distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.", "populationDescription": "All available 6MWD has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "143"}, {"groupId": "OG001", "value": "111"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "294.2", "spread": "131.2"}, {"groupId": "OG001", "value": "273.8", "spread": "142.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in 6MWD From Baseline", "populationDescription": "All available data has been reported", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Between baseline and 30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "260"}, {"groupId": "OG001", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31.6", "spread": "106.4"}, {"groupId": "OG001", "value": "-0.9", "spread": "83.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in 6MWD From Baseline", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Between baseline and 6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "233"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "25.9", "spread": "100.6"}, {"groupId": "OG001", "value": "0.66", "spread": "99.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in 6MWD From Baseline", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "191"}, {"groupId": "OG001", "value": "166"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "33.9", "spread": "99.6"}, {"groupId": "OG001", "value": "5.5", "spread": "115.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in 6MWD From Baseline", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Between baseline and 24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "142"}, {"groupId": "OG001", "value": "110"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.5", "spread": "103.0"}, {"groupId": "OG001", "value": "1.1", "spread": "133.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Kansas City Cardiomyopathy Questionnaire (KCCQ) QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "309"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "53.2", "spread": "22.8"}, {"groupId": "OG001", "value": "51.6", "spread": "23.3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "279"}, {"groupId": "OG001", "value": "275"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "70.9", "spread": "21.1"}, {"groupId": "OG001", "value": "54.6", "spread": "24.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "252"}, {"groupId": "OG001", "value": "237"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "73.0", "spread": "21.3"}, {"groupId": "OG001", "value": "59.0", "spread": "24.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "189"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "71.8", "spread": "22.2"}, {"groupId": "OG001", "value": "60.2", "spread": "24.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "KCCQ QoL Scores", "description": "The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "175"}, {"groupId": "OG001", "value": "138"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "71.3", "spread": "23.3"}, {"groupId": "OG001", "value": "58.9", "spread": "25.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 30 days KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available paired data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "Between baseline and 30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "279"}, {"groupId": "OG001", "value": "272"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "16.9", "spread": "22.8"}, {"groupId": "OG001", "value": "2.1", "spread": "18.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 6 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available paired data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "Between baseline and 6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "252"}, {"groupId": "OG001", "value": "236"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18.5", "spread": "24.9"}, {"groupId": "OG001", "value": "5.3", "spread": "23.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 12 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available paired data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "188"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.0", "spread": "25.4"}, {"groupId": "OG001", "value": "5.1", "spread": "24.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in KCCQ QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) and 24 months KCCQ score.\n\nThe Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. The KCCQ tool quantifies the following six (6) distinct domains and two (2) summary scores: KCCQ Symptom Domain, KCCQ Physical Function Domain, KCCQ Quality of Life Domain, KCCQ Social Limitation Domain, KCCQ Self-efficacy Domain, KCCQ Symptom Stability Domain, Clinical Summary Score and Overall Summary Score.\n\nClinical Summary Score includes total symptom and physical function scores to correspond with NYHA Classification.\n\nOverall Summary Score includes the total symptom, physical function, social limitations and quality of life scores.", "populationDescription": "All available paired data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "Between baseline and 24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "175"}, {"groupId": "OG001", "value": "138"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.4", "spread": "25.8"}, {"groupId": "OG001", "value": "3.4", "spread": "26.5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "299"}, {"groupId": "OG001", "value": "308"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "33.0", "spread": "9.1"}, {"groupId": "OG001", "value": "32.6", "spread": "10.0"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "46.7", "spread": "12.7"}, {"groupId": "OG001", "value": "13.0", "spread": "12.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "278"}, {"groupId": "OG001", "value": "272"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "39.2", "spread": "9.2"}, {"groupId": "OG001", "value": "33.6", "spread": "9.9"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "51.4", "spread": "11.5"}, {"groupId": "OG001", "value": "46.1", "spread": "13.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 scores on a points scale", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "251"}, {"groupId": "OG001", "value": "237"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "39.0", "spread": "10.3"}, {"groupId": "OG001", "value": "34.2", "spread": "9.9"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "52.1", "spread": "10.3"}, {"groupId": "OG001", "value": "47.0", "spread": "12.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 scores on a points scale", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}, {"groupId": "OG001", "value": "190"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "38.7", "spread": "10.2"}, {"groupId": "OG001", "value": "34.6", "spread": "10.8"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "51.3", "spread": "10.8"}, {"groupId": "OG001", "value": "48.2", "spread": "13.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "SF-36 QoL Scores", "description": "The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 scores on a points scale", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "174"}, {"groupId": "OG001", "value": "137"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "38.7", "spread": "10.4"}, {"groupId": "OG001", "value": "33.7", "spread": "9.8"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "50.6", "spread": "12.1"}, {"groupId": "OG001", "value": "47.2", "spread": "12.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 30 days SF-36. The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "Between baseline and 30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "276"}, {"groupId": "OG001", "value": "269"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.0", "spread": "8.9"}, {"groupId": "OG001", "value": "0.6", "spread": "8.1"}]}]}, {"title": "SF_36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.2", "spread": "12.2"}, {"groupId": "OG001", "value": "0.4", "spread": "12.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 6 months days SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "Between baseline and 6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "248"}, {"groupId": "OG001", "value": "234"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.5", "spread": "10.2"}, {"groupId": "OG001", "value": "1.0", "spread": "8.7"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "12.2"}, {"groupId": "OG001", "value": "1.1", "spread": "10.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 12 month SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "215"}, {"groupId": "OG001", "value": "187"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "10.4"}, {"groupId": "OG001", "value": "0.8", "spread": "9.8"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3", "spread": "13.2"}, {"groupId": "OG001", "value": "1.9", "spread": "13.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in SF-36 QoL Scores From Baseline", "description": "Paired data looking at difference between the baseline SF-36 and 24 months SF-36.\n\nThe 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. with a range of possible subscale scores from 0 to 100, with 100 representing the least burden of symptoms. There are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS).", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "SF-36 score on a points scale", "timeFrame": "Between baseline and 24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}, {"groupId": "OG001", "value": "136"}]}], "classes": [{"title": "SF-36 PCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "10.4"}, {"groupId": "OG001", "value": "0.7", "spread": "10.6"}]}]}, {"title": "SF-36 MCS", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8", "spread": "14.2"}, {"groupId": "OG001", "value": "-0.3", "spread": "12.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Surgery (Including Type of Surgery), New Use of CRT, New Use of Single or Dual Chamber Pacemaker, Permanent LVAD Implant, Heart Transplant, Additional MitraClip Device Intervention in Device Group", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Through 5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "Mitral Valve Surgery Elective - Repair", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "Mitral Valve Surgery Elective - Replacement", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "Mitral Valve Surgery Non Elective - Repair", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Mitral Valve Surgery Non Elective - Replacement", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "New Use of CRT", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "11"}]}]}, {"title": "New use of single or dual chamber Pacemaker", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "10"}]}]}, {"title": "Permanent LVAD Implant", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "18"}]}]}, {"title": "Heart Transplant", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "11"}]}]}, {"title": "Additional MitraClip Device Intervention", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "NA", "comment": "MitraClip Intervention is not applicable for Control Group"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "De Novo MitraClip Device Intervention in Control Group", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Through 5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "NA", "comment": "This is only applicable for Control Group"}, {"groupId": "OG001", "value": "67"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for 6MWD", "description": "Where responder is defined as alive and experiencing an improvement of 24 meters and 50 meters (difference in proportion of responders between Device and Control groups)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "191"}, {"groupId": "OG001", "value": "166"}]}], "classes": [{"title": "Experiencing Improvement >= 24 meters", "categories": [{"measurements": [{"groupId": "OG000", "value": "100"}, {"groupId": "OG001", "value": "66"}]}]}, {"title": "Experiencing Improvement >= 50 meters", "categories": [{"measurements": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "42"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for 6MWD", "description": "Where responder is defined as alive and experiencing an improvement of 24 meters and 50 meters (difference in proportion of responders between Device and Control groups)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "106"}, {"groupId": "OG001", "value": "72"}]}], "classes": [{"title": "Experiencing Improvement >= 24 meters", "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "34"}]}]}, {"title": "Experiencing Improvement >= 50 meters", "categories": [{"measurements": [{"groupId": "OG000", "value": "34"}, {"groupId": "OG001", "value": "23"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "160"}, {"groupId": "OG001", "value": "130"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "32"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "115"}, {"groupId": "OG001", "value": "89"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "populationDescription": "All available echocardiogram data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "43"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "28"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for LVEDV Index", "description": "Where responder is defined as alive and experiencing an improvement of 12 ml/m2 (difference in proportion of responders between Device and Control groups)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for QoL (KCCQ)", "description": "Where responder is defined as alive and experiencing an improvement of 5 points (difference in proportion of responders between Device and Control groups)", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "188"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "151"}, {"groupId": "OG001", "value": "103"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Responder Analysis for QoL (KCCQ)", "description": "Where responder is defined as alive and experiencing an improvement of 5 points (difference in proportion of responders between Device and Control groups)", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "128"}, {"groupId": "OG001", "value": "90"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "46"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Each Subscale for QoL (KCCQ)", "description": "difference in means between Device and Control groups for the Kansas City Cardiomyopathy Questionnaire (KCCQ) for the physical limitation and symptom stability scores.", "populationDescription": "219 subjects from device group and 189 subjects from control group analyzed.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Randomized Group", "description": "Randomized group contains both Device and Control Group"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "408"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9.90", "lowerLimit": "5.51", "upperLimit": "14.29"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Each Subscale for QoL (KCCQ)", "description": "difference in means between Device and Control groups for the Kansas City Cardiomyopathy Questionnaire (KCCQ) for the physical limitation and symptom stability scores.", "populationDescription": "128 subjects in the device group and 90 subjects in the control group were analyzed.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "KCCQ score on a points scale", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "Randomized Group", "description": "Randomized group contains both Device and Control Group"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8.01", "lowerLimit": "1.68", "upperLimit": "14.35"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Length of Index Hospitalization for MitraClip Procedure (Device Group)", "description": "Length of stay in the hospital for the MitraClip Index procedure (device group)", "populationDescription": "Data was available for 293 subjects out of 302 subjects in the device group.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Before MitraClip procedure on day 0", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "293"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.5", "spread": "2.3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Hospitalizations and Reason for Hospitalization (i.e. Heart Failure, Cardiovascular, Non-cardiovascular)", "description": "in each of the Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "Heart Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "118"}]}]}, {"title": "Cardiovascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "54"}]}]}, {"title": "Non-Cardiovascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "95"}, {"groupId": "OG001", "value": "97"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Hospitalizations and Reason for Hospitalization (i.e. Heart Failure, Cardiovascular, Non-cardiovascular)", "description": "in each of the Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "Heart Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "151"}]}]}, {"title": "Cardiovascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "72"}]}]}, {"title": "Non-Cardiovascular", "categories": [{"measurements": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "128"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Alive and Out of Hospital", "description": "mean no of days alive and out of hospital in both Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of days", "timeFrame": "From the time of randomization to 12 months", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "316.6", "spread": "93.9"}, {"groupId": "OG001", "value": "305.4", "spread": "98.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Alive and Out of Hospital", "description": "mean Number of days alive and out of hospital for the Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "From the time of randomization to 24 months", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "579.4", "spread": "234.0"}, {"groupId": "OG001", "value": "521.1", "spread": "245"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Alive and Out of Hospital", "description": "Mean Number of days alive and out of hospital for the Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "From the time of randomization to 3 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "799.0", "spread": "380.9"}, {"groupId": "OG001", "value": "676.6", "spread": "389.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Alive and Out of Hospital", "description": "difference in medians between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "From the time of randomization to 4 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "979.3", "spread": "527.4"}, {"groupId": "OG001", "value": "797.5", "spread": "527.4"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Alive and Out of Hospital", "description": "difference in medians between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "From the time of randomization to 5 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1123.5", "spread": "664.8"}, {"groupId": "OG001", "value": "894.8", "spread": "655.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9.2", "spread": "14.7"}, {"groupId": "OG001", "value": "9.6", "spread": "16.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "13.0", "spread": "20.0"}, {"groupId": "OG001", "value": "13.9", "spread": "19.8"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "mean Number of days hospitalized from the \"Treatment\" visit for the Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "3 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18.4", "spread": "28.3"}, {"groupId": "OG001", "value": "17.5", "spread": "22.7"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "difference in medians between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "4 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "21.3", "spread": "31.1"}, {"groupId": "OG001", "value": "19.0", "spread": "23.9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Days Hospitalized From the \"Treatment\" Visit", "description": "difference in medians between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "5 Years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23.8", "spread": "33.7"}, {"groupId": "OG001", "value": "19.8", "spread": "24.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.10"}, {"groupId": "OG001", "value": "0.04", "spread": "0.09"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.10"}, {"groupId": "OG001", "value": "0.04", "spread": "0.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.10"}, {"groupId": "OG001", "value": "0.05", "spread": "0.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.10"}, {"groupId": "OG001", "value": "0.05", "spread": "0.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Alive Time in Hospital", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Number of Days", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "311"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.10"}, {"groupId": "OG001", "value": "0.05", "spread": "0.08"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Subjects Living in the Baseline Location", "description": "Subjects living in the baseline location include : home, retirement home, nursing facility and other location.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "223"}, {"groupId": "OG001", "value": "206"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "217"}, {"groupId": "OG001", "value": "198"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Subjects Living in the Baseline Location", "description": "Subjects living in the baseline location include : home, retirement home, nursing facility and other location.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "130"}, {"groupId": "OG001", "value": "87"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Subjects Living in the Baseline Location", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "154"}, {"groupId": "OG001", "value": "113"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "150"}, {"groupId": "OG001", "value": "108"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Subjects Living in the Baseline Location", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}, {"groupId": "OG001", "value": "89"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "129"}, {"groupId": "OG001", "value": "86"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Proportion of Subjects Living in the Baseline Location", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "107"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "98"}, {"groupId": "OG001", "value": "72"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Replacement Rates", "description": "Subjects with mitral valve replacements in the Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Replacement Rates", "description": "Subjects with mitral valve replacements in the Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Valve Replacement Rates", "description": "summarized and compared between Device and Control groups", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New Onset of Permanent Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "13"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New Onset of Permanent Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "15"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New Onset of Permanent Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New Onset of Permanent Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New Onset of Permanent Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "23"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Mitral Stenosis", "description": "Defined as a mitral valve orifice area of less than 1.5 cm2 as measured by the Echocardiography Core Laboratory", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinically Significant Atrial Septal Defect (ASD) That Requires Intervention", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Device-related Complications in Device Group Subjects and Control Group Subjects Who Undergo the MitraClip Procedure", "reportingStatus": "NOT_POSTED", "timeFrame": "Through 5 years", "denomUnitsSelected": "Participants"}, {"type": "OTHER_PRE_SPECIFIED", "title": "Brain Natriuretic Peptide (BNP) or N-terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP Levels)", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "BNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "208"}, {"groupId": "OG001", "value": "209"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1014.77", "spread": "1085.98"}, {"groupId": "OG001", "value": "1017.13", "spread": "1212.77"}]}]}, {"title": "NT-proBNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "85"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5174.33", "spread": "6566.61"}, {"groupId": "OG001", "value": "5943.86", "spread": "8437.61"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "BNP or NT-proBNP Levels", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "BNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "193"}, {"groupId": "OG001", "value": "188"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "875.91", "spread": "931.18"}, {"groupId": "OG001", "value": "1065.55", "spread": "1206.34"}]}]}, {"title": "NT-proBNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "77"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4907.58", "spread": "7483.72"}, {"groupId": "OG001", "value": "5244.16", "spread": "7851.05"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "BNP or NT-proBNP Levels", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "BNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "146"}, {"groupId": "OG001", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "621.45", "spread": "606.99"}, {"groupId": "OG001", "value": "808.26", "spread": "1711.71"}]}]}, {"title": "NT-proBNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "61"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3362.49", "spread": "4332.12"}, {"groupId": "OG001", "value": "3977.80", "spread": "5689.70"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "308"}]}], "classes": [{"categories": [{"title": "0", "measurements": [{"groupId": "OG000", "value": "170"}, {"groupId": "OG001", "value": "158"}]}, {"title": "1", "measurements": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "55"}]}, {"title": "2", "measurements": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "58"}]}, {"title": "3", "measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "35"}]}, {"title": "4", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}]}, {"title": "5", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "278"}, {"groupId": "OG001", "value": "276"}]}], "classes": [{"categories": [{"title": "0", "measurements": [{"groupId": "OG000", "value": "169"}, {"groupId": "OG001", "value": "129"}]}, {"title": "1", "measurements": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "54"}]}, {"title": "2", "measurements": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "49"}]}, {"title": "3", "measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "34"}]}, {"title": "4", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "8"}]}, {"title": "5", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "250"}, {"groupId": "OG001", "value": "234"}]}], "classes": [{"categories": [{"title": "0", "measurements": [{"groupId": "OG000", "value": "145"}, {"groupId": "OG001", "value": "120"}]}, {"title": "1", "measurements": [{"groupId": "OG000", "value": "60"}, {"groupId": "OG001", "value": "48"}]}, {"title": "2", "measurements": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "38"}]}, {"title": "3", "measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "20"}]}, {"title": "4", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "8"}]}, {"title": "5", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Modified Rankin Scale Score", "description": "MODIFIED RANKIN SCALE SCORE DESCRIPTIONS:\n\n0- No symptoms at all; 1- No significant disability despite symptoms; able to carry out all usual duties and activities; 2- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3- Moderate disability; requiring some help, but able to walk without assistance; 4- Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5- Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6- Dead", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "189"}]}], "classes": [{"categories": [{"title": "0", "measurements": [{"groupId": "OG000", "value": "134"}, {"groupId": "OG001", "value": "100"}]}, {"title": "1", "measurements": [{"groupId": "OG000", "value": "42"}, {"groupId": "OG001", "value": "40"}]}, {"title": "2", "measurements": [{"groupId": "OG000", "value": "34"}, {"groupId": "OG001", "value": "27"}]}, {"title": "3", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "14"}]}, {"title": "4", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "7"}]}, {"title": "5", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Major Bleeding", "description": "Major bleeding is defined as bleeding \u2265 Type 3 based on a modified Bleeding Academic Research Consortium (BARC) definition", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "3"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Prolonged Ventilation", "description": "Defined as pulmonary insufficiency requiring ventilatory support for greater than 48 hours post-catheterization", "reportingStatus": "NOT_POSTED", "timeFrame": "30 days", "denomUnitsSelected": "Participants"}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of Guideline Directed Medical Therapy (GDMT)", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}, {"groupId": "OG001", "value": "115"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.18", "spread": "15.19"}, {"groupId": "OG001", "value": "13.44", "spread": "13.56"}]}]}, {"title": "Angiotensin-Receptor Blockers (ARB)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}, {"groupId": "OG001", "value": "71"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.21", "spread": "9.37"}, {"groupId": "OG001", "value": "12.35", "spread": "8.69"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "153"}, {"groupId": "OG001", "value": "154"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.51", "spread": "11.62"}, {"groupId": "OG001", "value": "28.96", "spread": "34.12"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "275"}, {"groupId": "OG001", "value": "278"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "31.91", "spread": "24.90"}, {"groupId": "OG001", "value": "29.92", "spread": "25.79"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "25"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "59.61", "spread": "43.81"}, {"groupId": "OG001", "value": "42.80", "spread": "26.97"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "50"}, {"groupId": "OG001", "value": "55"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "139.85", "spread": "108.46"}, {"groupId": "OG001", "value": "109.27", "spread": "86.45"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "9"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.64", "spread": "9.31"}, {"groupId": "OG001", "value": "9.65", "spread": "6.80"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "138"}, {"groupId": "OG001", "value": "115"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.61", "spread": "15.01"}, {"groupId": "OG001", "value": "13.53", "spread": "13.68"}]}]}, {"title": "Angiotensin Receptor Blockers (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "65"}, {"groupId": "OG001", "value": "75"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.68", "spread": "9.34"}, {"groupId": "OG001", "value": "11.89", "spread": "8.76"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "154"}, {"groupId": "OG001", "value": "154"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.21", "spread": "11.56"}, {"groupId": "OG001", "value": "29.48", "spread": "34.36"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "278"}, {"groupId": "OG001", "value": "281"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.12", "spread": "24.81"}, {"groupId": "OG001", "value": "29.25", "spread": "25.26"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "29"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "56.38", "spread": "42.76"}, {"groupId": "OG001", "value": "43.79", "spread": "27.15"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "57"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "133.41", "spread": "108.29"}, {"groupId": "OG001", "value": "110.53", "spread": "87.72"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "12"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.17", "spread": "11.15"}, {"groupId": "OG001", "value": "8.85", "spread": "5.98"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE I", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "143"}, {"groupId": "OG001", "value": "116"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.22", "spread": "14.59"}, {"groupId": "OG001", "value": "12.90", "spread": "12.96"}]}]}, {"title": "ARB", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "68"}, {"groupId": "OG001", "value": "79"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.73", "spread": "8.93"}, {"groupId": "OG001", "value": "12.02", "spread": "8.63"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "161"}, {"groupId": "OG001", "value": "160"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.16", "spread": "11.19"}, {"groupId": "OG001", "value": "29.42", "spread": "32.68"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "285"}, {"groupId": "OG001", "value": "284"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.01", "spread": "24.94"}, {"groupId": "OG001", "value": "28.53", "spread": "25.13"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "55.48", "spread": "41.64"}, {"groupId": "OG001", "value": "48.59", "spread": "34.90"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "63"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "133.82", "spread": "104.93"}, {"groupId": "OG001", "value": "109.01", "spread": "87.22"}]}]}, {"title": "ARNI", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "23"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10.13", "spread": "8.15"}, {"groupId": "OG001", "value": "7.68", "spread": "4.71"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "143"}, {"groupId": "OG001", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.73", "spread": "13.56"}, {"groupId": "OG001", "value": "12.41", "spread": "12.82"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "73"}, {"groupId": "OG001", "value": "81"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.76", "spread": "9.21"}, {"groupId": "OG001", "value": "11.90", "spread": "8.45"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}, {"groupId": "OG001", "value": "162"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.33", "spread": "12.17"}, {"groupId": "OG001", "value": "29.45", "spread": "32.58"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "287"}, {"groupId": "OG001", "value": "287"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.10", "spread": "24.99"}, {"groupId": "OG001", "value": "28.19", "spread": "24.65"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "56.85", "spread": "41.50"}, {"groupId": "OG001", "value": "48.56", "spread": "34.95"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "60"}, {"groupId": "OG001", "value": "68"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "136.51", "spread": "99.05"}, {"groupId": "OG001", "value": "108.74", "spread": "87.89"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "30"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10.36", "spread": "7.57"}, {"groupId": "OG001", "value": "7.99", "spread": "4.51"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACe Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.35", "spread": "13.36"}, {"groupId": "OG001", "value": "12.32", "spread": "12.91"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "78"}, {"groupId": "OG001", "value": "83"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.86", "spread": "9.10"}, {"groupId": "OG001", "value": "11.67", "spread": "8.09"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "173"}, {"groupId": "OG001", "value": "165"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.36", "spread": "12.30"}, {"groupId": "OG001", "value": "28.98", "spread": "32.00"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "288"}, {"groupId": "OG001", "value": "290"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.50", "spread": "25.15"}, {"groupId": "OG001", "value": "27.66", "spread": "23.70"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}, {"groupId": "OG001", "value": "39"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "54.81", "spread": "41.50"}, {"groupId": "OG001", "value": "45.53", "spread": "33.30"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "60"}, {"groupId": "OG001", "value": "76"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "135.20", "spread": "97.01"}, {"groupId": "OG001", "value": "102.29", "spread": "85.28"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "35"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10.41", "spread": "7.34"}, {"groupId": "OG001", "value": "8.52", "spread": "5.40"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported and includes subjects on the drugs mentioned below. Not all subjects were on all thedrugs.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "150"}, {"groupId": "OG001", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.23", "spread": "13.29"}, {"groupId": "OG001", "value": "12.28", "spread": "12.87"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "81"}, {"groupId": "OG001", "value": "87"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.42", "spread": "8.88"}, {"groupId": "OG001", "value": "11.13", "spread": "7.87"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "179"}, {"groupId": "OG001", "value": "170"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.24", "spread": "11.91"}, {"groupId": "OG001", "value": "28.97", "spread": "31.50"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "289"}, {"groupId": "OG001", "value": "291"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.70", "spread": "24.66"}, {"groupId": "OG001", "value": "27.83", "spread": "23.79"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "43"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "53.37", "spread": "41.58"}, {"groupId": "OG001", "value": "44.53", "spread": "32.50"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "82"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "132.54", "spread": "93.88"}, {"groupId": "OG001", "value": "101.92", "spread": "86.30"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "39"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.03", "spread": "7.25"}, {"groupId": "OG001", "value": "9.68", "spread": "5.89"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "152"}, {"groupId": "OG001", "value": "124"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.10", "spread": "13.08"}, {"groupId": "OG001", "value": "12.37", "spread": "12.89"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.28", "spread": "8.85"}, {"groupId": "OG001", "value": "11.03", "spread": "7.83"}]}]}, {"title": "Aldosterone Antagonist", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "183"}, {"groupId": "OG001", "value": "171"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.37", "spread": "11.84"}, {"groupId": "OG001", "value": "29.06", "spread": "31.39"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "289"}, {"groupId": "OG001", "value": "291"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.59", "spread": "24.26"}, {"groupId": "OG001", "value": "27.78", "spread": "23.80"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "43"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "51.63", "spread": "40.59"}, {"groupId": "OG001", "value": "44.59", "spread": "32.55"}]}]}, {"title": "Vasodilators", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "64"}, {"groupId": "OG001", "value": "83"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "129.51", "spread": "93.77"}, {"groupId": "OG001", "value": "100.74", "spread": "85.36"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "71"}, {"groupId": "OG001", "value": "44"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.04", "spread": "7.29"}, {"groupId": "OG001", "value": "9.54", "spread": "5.77"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Average Dosages of GDMT", "populationDescription": "All available data has been reported", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "153"}, {"groupId": "OG001", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.02", "spread": "13.03"}, {"groupId": "OG001", "value": "12.35", "spread": "12.88"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "84"}, {"groupId": "OG001", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.29", "spread": "8.78"}, {"groupId": "OG001", "value": "11.02", "spread": "7.82"}]}]}, {"title": "Aldosterone Antagonist", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "185"}, {"groupId": "OG001", "value": "172"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.30", "spread": "11.84"}, {"groupId": "OG001", "value": "28.99", "spread": "31.13"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "289"}, {"groupId": "OG001", "value": "291"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "30.60", "spread": "24.16"}, {"groupId": "OG001", "value": "27.78", "spread": "23.80"}]}]}, {"title": "Vasodilators Nitrate", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "44"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "52.41", "spread": "40.35"}, {"groupId": "OG001", "value": "44.28", "spread": "32.27"}]}]}, {"title": "Vasodilators", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "65"}, {"groupId": "OG001", "value": "84"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "130.83", "spread": "93.29"}, {"groupId": "OG001", "value": "100.07", "spread": "84.45"}]}]}, {"title": "ARN Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "45"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.53", "spread": "7.34"}, {"groupId": "OG001", "value": "9.41", "spread": "5.81"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Changes in GDMT Dosage From Baseline", "populationDescription": "Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "283"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "23"}]}]}, {"title": "Angiotensin-Receptor Blocker (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "282"}, {"groupId": "OG001", "value": "282"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "282"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "25"}]}]}, {"title": "Beta Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "283"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "60"}, {"groupId": "OG001", "value": "48"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "281"}, {"groupId": "OG001", "value": "282"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "13"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Changes in GDMT Dosage From Baseline to 6 Months", "populationDescription": "Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "254"}, {"groupId": "OG001", "value": "245"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "41"}]}]}, {"title": "Angiotensin-Receptor Blockers (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "252"}, {"groupId": "OG001", "value": "244"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "27"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "35"}]}]}, {"title": "Beta Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "254"}, {"groupId": "OG001", "value": "245"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "74"}, {"groupId": "OG001", "value": "60"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "252"}, {"groupId": "OG001", "value": "245"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "18"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "251"}, {"groupId": "OG001", "value": "245"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Changes in GDMT Dosage From Baseline and 12 Months", "populationDescription": "Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "219"}, {"groupId": "OG001", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "37"}]}]}, {"title": "Angiotension-Receptor Blockers (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "217"}, {"groupId": "OG001", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "38"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "220"}, {"groupId": "OG001", "value": "202"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "44"}]}]}, {"title": "Beta Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}, {"groupId": "OG001", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "76"}, {"groupId": "OG001", "value": "66"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "220"}, {"groupId": "OG001", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "19"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "220"}, {"groupId": "OG001", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Changes in GDMT Dosage From Baseline and 24 Months", "populationDescription": "Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "24"}]}]}, {"title": "Angiotensin-Receptor Blockers (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "21"}]}]}, {"title": "Aldosterone Antagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "130"}, {"groupId": "OG001", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "21"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "34"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "91"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "11"}]}]}, {"title": "Vasodilators (Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "131"}, {"groupId": "OG001", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "14"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "populationDescription": "Not all subjects were on all the drugs.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "149"}, {"groupId": "OG001", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "25"}]}]}, {"title": "Angiotensin-ReceptorBlockers (ARBs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "147"}, {"groupId": "OG001", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "26"}]}]}, {"title": "AldosteroneAntagonists", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "107"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "32"}]}]}, {"title": "Beta Blockers", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "149"}, {"groupId": "OG001", "value": "107"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "52"}, {"groupId": "OG001", "value": "44"}]}]}, {"title": "Vasodilators (Nitrate)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "9"}]}]}, {"title": "Vasodilators(Hydralazine)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "106"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "123"}, {"groupId": "OG001", "value": "84"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "21"}]}]}, {"title": "ARBS", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}, {"groupId": "OG001", "value": "84"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "27"}]}]}, {"title": "Aldosterone Antagonist", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}, {"groupId": "OG001", "value": "84"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "31"}]}]}, {"title": "Beta Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "85"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "50"}, {"groupId": "OG001", "value": "35"}]}]}, {"title": "Vasodilators Nitrate", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "83"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "Vasodilators", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "82"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT and GDMT Dosage From Baseline", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE Inhibitors", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "18"}]}]}, {"title": "ARBs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "23"}]}]}, {"title": "Aldosterone Antagonist", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "15"}]}]}, {"title": "Beta Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "95"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "33"}]}]}, {"title": "Vasodilators Nitrate", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "8"}]}]}, {"title": "Vasodilators", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}, {"groupId": "OG001", "value": "66"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "13"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Change in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 30 days", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ACE-Inhibitors (Increase > 100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "ARB (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARB (Increase > 100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Aldosterone Antagonists (Decrease > 50% or stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Aldosterone Antagonists (Increase>100%orNewClass)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "Beta Blockers (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Beta Blockers (Increase >100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "Vasodilators (Nitrate) Decrease>50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators (Nitrate) Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators (Hydralazine) Decrease>50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators(Hydralazine)Increase >100% orNewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "ARN Inhibitors - Decrease>50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors - Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 6 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-I (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "4"}]}]}, {"title": "ACE-I (Increase > 100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "4"}]}]}, {"title": "ARB (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "ARB (Increase > 100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "9"}]}]}, {"title": "Aldosterone Antagonists (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Aldosterone Antagonists (Increase > 100% or NewCl)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "Beta Blockers (Decrease > 50% or Stop)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "10"}]}]}, {"title": "Beta Blockers (Increase > 100% or New Class)", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "9"}]}]}, {"title": "Vasodilators (Nitrate) Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators (Nitrate) Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "Vasodilators (Hydralazine) Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators(Hydralazine)Increase>100% orNewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "6"}]}]}, {"title": "ARN Inhibitors Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "12"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "ACE-Inhibitors Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "8"}]}]}, {"title": "ARBs Decrease >50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "ARBs Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "Aldosterone Antagonists Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "Aldosterone Antagonists Increase>100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "8"}]}]}, {"title": "Beta Blockers Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "16"}]}]}, {"title": "Beta Blockers Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "Vasodilators(Nitrate) Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators(Nitrate) Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}]}]}, {"title": "Vasodilators(Hydralazine) Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Vasodilators(Hydralazine) Increase>100%orNewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "ARN Inhibitors Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN inhibitors Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number of Subjects With Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 24 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "6"}]}]}, {"title": "ACE Inhibitors Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "11"}]}]}, {"title": "ARBs Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "ARBs Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "16"}]}]}, {"title": "Aldosterone Antagonists Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "Aldosterone Antagonists Increase>100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "10"}]}]}, {"title": "Beta Blockers Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "26"}]}]}, {"title": "Beta Blockers Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "19"}]}]}, {"title": "Vasodilators(Nitrate) Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Nitrate) Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "11"}]}]}, {"title": "Vasodilators(Hydralazine)Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Hydralazine) Increase>100%orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "20"}]}]}, {"title": "ARN Inhibitors Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors Increase > 100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "24"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 3 years", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "ACE Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "ARBs Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "ARBs Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "19"}]}]}, {"title": "Aldosterone Antagonists Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "Aldosterone AntagonistsIncrease>100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "14"}]}]}, {"title": "Beta Blockers Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "29"}]}]}, {"title": "Beta Blockers Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "32"}, {"groupId": "OG001", "value": "26"}]}]}, {"title": "Vasodilators(Nitrate) Decrease >50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Nitrate) Increase >100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "13"}]}]}, {"title": "Vasodilators(Hydralazine)Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Hydralazine)Increase>100%orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "24"}]}]}, {"title": "ARN Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "29"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "populationDescription": "All available data has been reported.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 4 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "ACE Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "12"}]}]}, {"title": "ARBs Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "ARBs Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "21"}]}]}, {"title": "Aldosterone Antagonists Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "Aldosterone AntagonistsIncrease>100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "32"}, {"groupId": "OG001", "value": "15"}]}]}, {"title": "Beta Blockers Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "32"}]}]}, {"title": "Beta Blockers Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "26"}]}]}, {"title": "Vasodilators(Nitrate) Decrease >50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Nitrate) Increase >100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "14"}]}]}, {"title": "Vasodilators(Hydralazine)Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "Vasodilators(Hydralazine)Increase>100%orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "26"}]}]}, {"title": "ARN Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "33"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "The Number and Reasons for Any Changes in GDMT From Baseline That Result in a Greater Than 100% Increase or Greater Than 50% Decrease in Dose", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Between baseline and 5 years", "groups": [{"id": "OG000", "title": "Device Group", "description": "MitraClip Device"}, {"id": "OG001", "title": "Control Group", "description": "Control group treated with medication"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "302"}, {"groupId": "OG001", "value": "312"}]}], "classes": [{"title": "ACE-Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "ACE Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "14"}]}]}, {"title": "ARBs Decrease > 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "ARBs Increase > 100% or NewClass", "categories": [{"measurements": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "22"}]}]}, {"title": "Aldosterone Antagonists Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "Aldosterone AntagonistsIncrease>100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "16"}]}]}, {"title": "Beta Blockers Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "34"}]}]}, {"title": "Beta Blockers Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "27"}]}]}, {"title": "Vasodilators(Nitrate) Decrease >50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Vasodilators(Nitrate) Increase >100% or New Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "15"}]}]}, {"title": "Vasodilators(Hydralazine)Decrease> 50% or Stop", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "3"}]}]}, {"title": "Vasodilators(Hydralazine)Increase>100%orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "27"}]}]}, {"title": "ARN Inhibitors Decrease > 50% orStop", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "ARN Inhibitors Increase > 100% orNew Class", "categories": [{"measurements": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "34"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiopulmonary Exercise (CPX) Testing", "description": "A substudy endpoint will utilize peak oxygen consumption oxygen uptake (VO2) as a parameter for cardiopulmonary exercise testing on a total of at least 50 and up to 100 subjects.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "populationDescription": "A total of 14 subjects were enrolled in the CPA sub study. However CPX data was available for only 2 subjects in the device group and 1 subject in the control group.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/kg/min", "timeFrame": "Baseline", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.85", "spread": "0.78"}, {"groupId": "OG001", "value": "6.00", "spread": "NA", "comment": "Data is available for only one subject. Hence Standard deviation is not applicable."}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiopulmonary Exercise (CPX) Testing", "description": "A substudy endpoint will utilize peak oxygen consumption oxygen uptake (VO2) as a parameter for cardiopulmonary exercise testing on a total of at least 50 and up to 100 subjects.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "populationDescription": "A total of 14 subjects participated in the CPX sub-study. CPX test data was available in 2 subjects in the device group and 1 subject in the control group.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/kg/min", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "14.50", "spread": "6.36"}, {"groupId": "OG001", "value": "6.80", "spread": "NA", "comment": "Data available for only 1 subject. Hence Standard deviation is not possible."}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Cardiopulmonary Exercise (CPX) Testing: Mean Changes in Peak VO2", "description": "Mean changes in peak VO2 (ml/kg/min) will be summarized at 12 months from baseline for the subset of patients who complete a CPX test at baseline and 12 months. A comparison of change from baseline between Device and Control groups will be presented.\n\nThe CPX analysis variables are:\n\n* Peak VO2 (ml/kg/min) - CPX Sub-study endpoint, descriptive analysis only, not powered for statistical significance\n* Exercise duration (min)\n* Peak workload (watts)\n* Maximum heart rate during exercise (beats/min)\n* Peak VE (l/min)\n* Respiratory Exchange Ratio (RER, VCO2/VO2)\n* VE/VCO2 slope\n* Ventilatory Threshold (ml/kg/min)\n* Borg scale\n* Exercise termination reason\n* Type of exercise (treadmill vs cycling)", "populationDescription": "A total of 14 subjects participated in the CPX sub-study. CPX test data was available in 2 subjects in the device group and 1 subject in the control group.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/kg/min", "timeFrame": "Between baseline and 12 months", "groups": [{"id": "OG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System"}, {"id": "OG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.65", "spread": "5.59"}, {"groupId": "OG001", "value": "0.80", "spread": "NA", "comment": "Data is available for only 1 subject."}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Health Economic Data", "reportingStatus": "NOT_POSTED", "timeFrame": "Through 5 years", "denomUnitsSelected": "Participants"}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "COAPT IDE - 60 Months and COAPT CAS - 12 months", "description": "TVT Registry Mitral module does not collect the serious adverse events for COAPT CAS group. Only AE table is being populated for the COAPT CAS group", "eventGroups": [{"id": "EG000", "title": "MitraClip System", "description": "Percutaneous mitral valve repair using MitraClip System\n\nMitraClip System: Percutaneous mitral valve repair using MitraClip System", "deathsNumAffected": 167, "deathsNumAtRisk": 302, "seriousNumAffected": 281, "seriousNumAtRisk": 302, "otherNumAffected": 239, "otherNumAtRisk": 302}, {"id": "EG001", "title": "Control Group", "description": "Patients with mitral regurgitation managed non-surgically based on standard hospital clinical practice.", "deathsNumAffected": 192, "deathsNumAtRisk": 312, "seriousNumAffected": 291, "seriousNumAtRisk": 312, "otherNumAffected": 234, "otherNumAtRisk": 312}, {"id": "EG002", "title": "COAPT CAS Group", "description": "subjects enrolled as part of the Continued Access Study with Percutaneous mitral valve repair using MitraClip System", "deathsNumAffected": 46, "deathsNumAtRisk": 162, "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 86, "otherNumAtRisk": 162}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 30, "numAffected": 25, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 14, "numAffected": 12, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Anaemia Macrocytic", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Anaemia of Chronic Disease", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Coagulopathy", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Haemorrhagic Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Iron Deficiency Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "LEUKOCYTOSIS", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "MICROCYTIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "PANCYTOPENIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "THROMBOCYTOPENIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ACUTE CORONARY SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ACUTE LEFT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 19, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ACUTE MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 14, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 25, "numAffected": 21, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ANGINA PECTORIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ANGINA UNSTABLE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ARTERIOSCLEROSIS CORONARY ARTERY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIAL FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 37, "numAffected": 28, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 33, "numAffected": 26, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIAL FLUTTER", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIAL SEPTAL DEFECT ACQUIRED", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIAL TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIAL THROMBOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "ATRIOVENTRICULAR BLOCK COMPLETE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "BRADYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC ARREST", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 28, "numAffected": 28, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 55, "numAffected": 42, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 133, "numAffected": 98, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC FAILURE ACUTE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 45, "numAffected": 35, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 51, "numAffected": 39, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC FAILURE CHRONIC", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 56, "numAffected": 41, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 69, "numAffected": 56, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC FAILURE CONGESTIVE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 136, "numAffected": 89, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 193, "numAffected": 105, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIAC TAMPONADE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIO-RESPIRATORY ARREST", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIOGENIC SHOCK", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 12, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 20, "numAffected": 20, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIOMYOPATHY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIOPULMONARY FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIORENAL SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CARDIOVASCULAR DECONDITIONING", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CONGESTIVE CARDIOMYOPATHY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CORONARY ARTERY DISEASE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CORONARY ARTERY OCCLUSION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "CORONARY ARTERY STENOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "INTRACARDIAC THROMBUS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ISCHAEMIC CARDIOMYOPATHY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 9, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LEFT VENTRICULAR DYSFUNCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LEFT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MITRAL VALVE INCOMPETENCE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 15, "numAffected": 14, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MITRAL VALVE STENOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MYOCARDIAL ISCHAEMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PALPITATIONS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERICARDIAL EFFUSION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERICARDIAL HAEMORRHAGE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SICK SINUS SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SUPRAVENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SYSTOLIC DYSFUNCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TACHYARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TORSADE DE POINTES", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRICUSPID VALVE INCOMPETENCE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENTRICULAR ARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENTRICULAR DYSSYNCHRONY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENTRICULAR EXTRASYSTOLES", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENTRICULAR FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 9, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 34, "numAffected": 21, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 40, "numAffected": 26, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VERTIGO", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CATARACT", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CONJUNCTIVITIS", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIPLOPIA", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VISION BLURRED", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ABDOMINAL PAIN UPPER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACQUIRED OESOPHAGEAL WEB", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ASCITES", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLITIS ISCHAEMIC", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLITIS ULCERATIVE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLONIC PSEUDO-OBSTRUCTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CONSTIPATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIABETIC GASTROPARESIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIVERTICULAR PERFORATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIVERTICULUM INTESTINAL", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIVERTICULUM INTESTINAL HAEMORRHAGIC", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSPHAGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENTEROCUTANEOUS FISTULA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENTEROVESICAL FISTULA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EROSIVE OESOPHAGITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FLATULENCE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTRITIS HAEMORRHAGIC", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROINTESTINAL ANGIODYSPLASIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 18, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 24, "numAffected": 20, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMATEMESIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMORRHOIDAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMORRHOIDS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HIATUS HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMPAIRED GASTRIC EMPTYING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INGUINAL HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INGUINAL HERNIA, OBSTRUCTIVE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTESTINAL ISCHAEMIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTESTINAL OBSTRUCTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTESTINAL PERFORATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "JEJUNITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LARGE INTESTINE PERFORATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOWER GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MEGACOLON", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MELAENA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NAUSEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ODYNOPHAGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGEAL ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PANCREATITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PANCREATITIS ACUTE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCTALGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCTITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RECTAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RECTAL PROLAPSE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RECTAL ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RECTAL ULCER HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RETROPERITONEAL HAEMATOMA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RETROPERITONEAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SMALL INTESTINAL OBSTRUCTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "UMBILICAL HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "UPPER GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VOLVULUS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ADVERSE DRUG REACTION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ASTHENIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CATHETER SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CATHETER SITE HAEMORRHAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHEST DISCOMFORT", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 14, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEATH", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 12, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 12, "numAffected": 12, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE BATTERY ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE DISLOCATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE ELECTRICAL FINDING", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE LEAD DAMAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE LEAD ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE MALFUNCTION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DRUG INTOLERANCE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EXERCISE TOLERANCE DECREASED", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FATIGUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GENERAL PHYSICAL HEALTH DETERIORATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HERNIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HERNIA OBSTRUCTIVE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MEDICAL DEVICE COMPLICATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MULTI-ORGAN FAILURE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NON-CARDIAC CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OEDEMA PERIPHERAL", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PYREXIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SUDDEN CARDIAC DEATH", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VESSEL PUNCTURE SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BILE DUCT STONE", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHOLECYSTITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHOLECYSTITIS ACUTE", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHOLELITHIASIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEPATIC CIRRHOSIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEPATIC MASS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ISCHAEMIC HEPATITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANAPHYLACTIC REACTION", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEART TRANSPLANT REJECTION", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMMUNOSUPPRESSION", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRANSPLANT REJECTION", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ABDOMINAL ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ABSCESS LIMB", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACQUIRED IMMUNODEFICIENCY SYNDROME", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BACTERIAL SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BRONCHITIS VIRAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BRONCHOPNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CLOSTRIDIAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CLOSTRIDIUM DIFFICILE COLITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CYSTITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE RELATED INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE RELATED SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIVERTICULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EMPHYSEMATOUS CYSTITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENTEROCOCCAL BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENTEROCOLITIS INFECTIOUS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ESCHERICHIA BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ESCHERICHIA INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FUNGAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GANGRENE", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROENTERITIS VIRAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HERPES ZOSTER", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMPLANT SITE INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INFLUENZA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INFUSION SITE CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "KLEBSIELLA BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOBAR PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOWER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGEAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OSTEOMYELITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PARAINFLUENZAE VIRUS INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIRECTAL ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERITONITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 33, "numAffected": 27, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 32, "numAffected": 28, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA BACTERIAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA INFLUENZAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA NECROTISING", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA STAPHYLOCOCCAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "POST VIRAL FATIGUE SYNDROME", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PYELONEPHRITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 20, "numAffected": 18, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 15, "numAffected": 13, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SEPSIS SYNDROME", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SEPTIC SHOCK", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 9, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SOFT TISSUE INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "STAPHYLOCOCCAL BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "STAPHYLOCOCCAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "STREPTOCOCCAL BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SUBCUTANEOUS ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRACHEOBRONCHITIS VIRAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TUBERCULOSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINARY TRACT INFECTION BACTERIAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINARY TRACT INFECTION FUNGAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "UROSEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANAEMIA POSTOPERATIVE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANAESTHETIC COMPLICATION PULMONARY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTERIOVENOUS FISTULA THROMBOSIS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTHROPOD BITE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC VALVE REPLACEMENT COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CERVICAL VERTEBRAL FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COMPLICATIONS OF TRANSPLANTED HEART", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CONTUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CRANIOCEREBRAL INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FACE INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FACIAL BONES FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FALL", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 14, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 15, "numAffected": 15, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FEMORAL NECK FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FEMUR FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FRACTURE DISPLACEMENT", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FRACTURED SACRUM", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROENTERITIS RADIATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMATURIA TRAUMATIC", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEAD INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HIP FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HUMERUS FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IN-STENT CORONARY ARTERY RESTENOSIS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LACERATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PELVIC FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "POCKET EROSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "POST PROCEDURAL HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "POST PROCEDURAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "POSTOPERATIVE ILEUS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCEDURAL COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCEDURAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCEDURAL HYPOTENSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROCEDURAL PAIN", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PUBIS FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RADIUS FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RIB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SPINAL COMPRESSION FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SPINAL FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SUBDURAL HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TOXICITY TO VARIOUS AGENTS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRAUMATIC HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRAUMATIC INTRACRANIAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "UPPER LIMB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VASCULAR ACCESS COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VASCULAR PSEUDOANEURYSM", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENA CAVA INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "WOUND", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC ENZYMES INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC OUTPUT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CATHETERISATION CARDIAC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLONOSCOPY", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DRUG LEVEL ABOVE THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EJECTION FRACTION DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ELECTROCARDIOGRAM AMBULATORY ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ELECTROCARDIOGRAM QRS COMPLEX PROLONGED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ELECTROCARDIOGRAM QT PROLONGED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ELECTROCARDIOGRAM ST SEGMENT ELEVATION", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENTEROCOCCUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMOGLOBIN DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INFLUENZA A VIRUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTERNATIONAL NORMALISED RATIO DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTERNATIONAL NORMALISED RATIO INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LABORATORY TEST ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LIVER FUNCTION TEST ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRANSAMINASES INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TROPONIN INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINE OUTPUT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "WHITE BLOOD CELL COUNT INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEHYDRATION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIABETES MELLITUS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIABETIC KETOACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ELECTROLYTE IMBALANCE", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FAILURE TO THRIVE", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FLUID OVERLOAD", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GOUT", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPERGLYCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPERKALAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOGLYCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOKALAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPONATRAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOVOLAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IRON DEFICIENCY", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LACTIC ACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "METABOLIC ACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "METABOLIC ALKALOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BACK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CERVICAL SPINAL STENOSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GOUTY ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTERVERTEBRAL DISC DEGENERATION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTERVERTEBRAL DISC PROTRUSION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUMBAR SPINAL STENOSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MUSCLE HAEMORRHAGE", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MUSCLE SPASMS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MUSCULAR WEAKNESS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MUSCULOSKELETAL CHEST PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NECK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OSTEOARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PAIN IN EXTREMITY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RHABDOMYOLYSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SPINAL COLUMN STENOSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VERTEBRAL FORAMINAL STENOSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANGIOSARCOMA METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "B-CELL LYMPHOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BASAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BONE SARCOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BREAST CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COLON CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEPATIC NEOPLASM MALIGNANT", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LEUKAEMIA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG ADENOCARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG ADENOCARCINOMA METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG CANCER METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LYMPHOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MULTIPLE MYELOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGEAL ADENOCARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGEAL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OVARIAN CANCER METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PANCREATIC CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROSTATE CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SKIN CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SQUAMOUS CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "THYROID CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TUMOUR HAEMORRHAGE", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CAROTID ARTERY DISEASE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CAROTID ARTERY STENOSIS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARPAL TUNNEL SYNDROME", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CEREBRAL HAEMORRHAGE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CEREBROVASCULAR ACCIDENT", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 12, "numAffected": 11, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CERVICOBRACHIAL SYNDROME", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CONVULSION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEMENTIA ALZHEIMER'S TYPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIZZINESS POSTURAL", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSARTHRIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EMBOLIC STROKE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMORRHAGE INTRACRANIAL", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEPATIC ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOAESTHESIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOXIC-ISCHAEMIC ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTRACRANIAL ANEURYSM", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTRACRANIAL HYPOTENSION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ISCHAEMIC STROKE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOSS OF CONSCIOUSNESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "METABOLIC ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PARKINSON'S DISEASE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PRESYNCOPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SCIATICA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SUBARACHNOID HAEMORRHAGE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SYNCOPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 14, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 24, "numAffected": 22, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TOXIC ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRANSIENT ISCHAEMIC ATTACK", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VERTEBRAL ARTERY OCCLUSION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CONFUSIONAL STATE", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DELIRIUM", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DISORIENTATION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MENTAL STATUS CHANGES", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PANIC ATTACK", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "AZOTAEMIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMATURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NEPHROLITHIASIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NEPHROPATHY", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL FAILURE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL FAILURE ACUTE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 49, "numAffected": 41, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 60, "numAffected": 51, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL FAILURE CHRONIC", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 12, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 21, "numAffected": 20, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL IMPAIRMENT", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL MASS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINARY RETENTION", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BENIGN PROSTATIC HYPERPLASIA", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VAGINAL HAEMORRHAGE", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACUTE PULMONARY OEDEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACUTE RESPIRATORY FAILURE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 22, "numAffected": 19, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 14, "numAffected": 14, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ASTHMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ATELECTASIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BRONCHIAL SECRETION RETENTION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHRONIC OBSTRUCTIVE PULMONARY DISORDER", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 16, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSPHONIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSPNOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 29, "numAffected": 23, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 18, "numAffected": 16, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DYSPNOEA EXERTIONAL", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EPISTAXIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMOPTYSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMOTHORAX", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPERCAPNIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOXIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INCREASED UPPER AIRWAY SECRETION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LARYNGEAL HAEMATOMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MEDIASTINAL HAEMORRHAGE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PLEURAL EFFUSION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 11, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 18, "numAffected": 14, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONIA ASPIRATION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMONITIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PNEUMOTHORAX", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY CONGESTION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY FIBROSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY HYPERTENSION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY OEDEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RALES", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RESPIRATORY DISTRESS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RESPIRATORY FAILURE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 19, "numAffected": 19, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SLEEP APNOEA SYNDROME", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANGIOEDEMA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIGITAL ULCER", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SKIN DISCOLOURATION", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SKIN ULCER", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "AORTIC SURGERY", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC PACEMAKER BATTERY REPLACEMENT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC PACEMAKER REPLACEMENT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHOLECYSTECTOMY", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTRECTOMY", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HEART TRANSPLANT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HIP ARTHROPLASTY", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMPLANTABLE DEFIBRILLATOR INSERTION", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMPLANTABLE DEFIBRILLATOR REPLACEMENT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INGUINAL HERNIA REPAIR", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MEDICAL DEVICE CHANGE", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERCUTANEOUS CORONARY INTERVENTION", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SPINAL FUSION SURGERY", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANGIOPATHY", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "AORTIC ANEURYSM", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "AORTIC STENOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTERIOSCLEROSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEEP VEIN THROMBOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FEMORAL ARTERIAL STENOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMATOMA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMODYNAMIC INSTABILITY", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMORRHAGE", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 27, "numAffected": 24, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 19, "numAffected": 18, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOVOLAEMIC SHOCK", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ILIAC ARTERY STENOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INTERMITTENT CLAUDICATION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ORTHOSTATIC HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIPHERAL ARTERIAL OCCLUSIVE DISEASE", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIPHERAL ARTERY ANEURYSM", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIPHERAL ISCHAEMIA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIPHERAL VASCULAR DISORDER", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SHOCK", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SHOCK HAEMORRHAGIC", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LEUKOPENIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NORMOCHROMIC NORMOCYTIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACUTE RIGHT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARRHYTHMIA SUPRAVENTRICULAR", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOTHYROIDISM", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BUNDLE BRANCH BLOCK LEFT", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC PERFORATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CHRONIC LEFT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOW CARDIAC OUTPUT SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MITRAL VALVE DISEASE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RIGHT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BLINDNESS UNILATERAL", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "EYE HAEMORRHAGE", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ABDOMINAL DISTENSION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DUODENAL VASCULAR ECTASIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROINTESTINAL VASCULAR MALFORMATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOCALISED INTRAABDOMINAL FLUID COLLECTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGEAL STENOSIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OESOPHAGITIS HAEMORRHAGIC", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TOOTHACHE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CYST", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DEVICE OCCLUSION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOTHERMIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "IMPLANT SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ISCHAEMIC ULCER", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MASS", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "THROMBOSIS IN DEVICE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ACUTE HEPATIC FAILURE", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC CIRRHOSIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NON-ALCOHOLIC STEATOHEPATITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "AMERICAN TRYPANOSOMIASIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "APPENDICITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CORONA VIRUS INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ESCHERICHIA SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTROENTERITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG INFECTION PSEUDOMONAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRACHEOBRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VIRAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BLADDER INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FOOT FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LIMB INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LIP INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LOWER LIMB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BARIUM SWALLOW ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BRAIN NATRIURETIC PEPTIDE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CARDIAC MONITORING", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NOROVIRUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DIABETES MELLITUS INADEQUATE CONTROL", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPERCALCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MALNUTRITION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "FRACTURE MALUNION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "JOINT EFFUSION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OSTEOLYSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RHEUMATOID ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BLADDER CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BREAST CANCER METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "GASTRIC CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LIPOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "LUNG NEOPLASM MALIGNANT", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NEOPLASM MALIGNANT", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ONCOLOGIC COMPLICATION", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "OROPHARYNGEAL CANCER STAGE UNSPECIFIED", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROSTATE CANCER METASTATIC", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "SQUAMOUS CELL CARCINOMA OF SKIN", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "DURAL FISTULA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ISCHAEMIC CEREBRAL INFARCTION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYDRONEPHROSIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROTEINURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "RENAL DISORDER", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "URINARY TRACT OBSTRUCTION", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PROSTATIC HAEMORRHAGE", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ORGANISING PNEUMONIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PULMONARY HILUM MASS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "TRACHEOMALACIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "CUTIS LAXA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PANNICULITIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "THROMBOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "VENOUS OCCLUSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ADRENAL INSUFFICIENCY", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HYPOTHYROIDISM", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "ARTERIOVENOUS FISTULA SITE HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BLOOD POTASSIUM DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "WEIGHT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "MALIGNANT PLEURAL EFFUSION", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "NEUROENDOCRINE CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "HAEMORRHAGIC STROKE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "BLADDER MASS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}, {"term": "PERIPHERAL EMBOLISM", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numAtRisk": 0}]}], "otherEvents": [{"term": "ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 19, "numAffected": 18, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 22, "numAffected": 20, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANAEMIA FOLATE DEFICIENCY", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANAEMIA MACROCYTIC", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANAEMIA OF CHRONIC DISEASE", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COAGULOPATHY", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMORRHAGIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "IRON DEFICIENCY ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LEUKOCYTOSIS", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LYMPHADENOPATHY MEDIASTINAL", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MACROCYTOSIS", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MICROCYTIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEPHROGENIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NORMOCHROMIC NORMOCYTIC ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PANCYTOPENIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SPLENIC INFARCTION", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SPLENOMEGALY", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "THROMBOCYTOPENIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACUTE MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANGINA PECTORIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANGINA UNSTABLE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATRIAL FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 28, "numAffected": 23, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 19, "numAffected": 16, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 162}]}, {"term": "ATRIAL FLUTTER", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATRIAL SEPTAL DEFECT ACQUIRED", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATRIAL TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATRIAL THROMBOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BRADYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC ARREST", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "CARDIAC FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC FAILURE ACUTE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC FAILURE CHRONIC", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC FAILURE CONGESTIVE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 31, "numAffected": 21, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIOGENIC SHOCK", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CYANOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTRACARDIAC THROMBUS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ISCHAEMIC CARDIOMYOPATHY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LEFT VENTRICULAR DYSFUNCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MITRAL VALVE INCOMPETENCE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 9, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MITRAL VALVE STENOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PALPITATIONS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PERICARDIAL EFFUSION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RIGHT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SICK SINUS SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SINUS TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SUPRAVENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRICUSPID VALVE INCOMPETENCE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VENTRICULAR ARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VENTRICULAR FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 20, "numAffected": 18, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATRIAL SEPTAL DEFECT", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEAFNESS", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEAFNESS NEUROSENSORY", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEAFNESS UNILATERAL", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EAR HAEMORRHAGE", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VERTIGO", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERPARATHYROIDISM", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERTHYROIDISM", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOTHYROIDISM", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "THYROIDITIS", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLEPHARITIS", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATARACT", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CONJUNCTIVAL HAEMORRHAGE", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIPLOPIA", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EYE HAEMORRHAGE", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EYE PAIN", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EYELID PTOSIS", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RETINAL VASCULAR OCCLUSION", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VISION BLURRED", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL DISCOMFORT", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL DISTENSION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL MASS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 9, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL PAIN LOWER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL PAIN UPPER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ASCITES", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COLITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CONSTIPATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DENTAL CARIES", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIVERTICULUM INTESTINAL", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIVERTICULUM INTESTINAL HAEMORRHAGIC", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DRY MOUTH", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DUODENAL ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPHAGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FAECAL INCONTINENCE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTRIC POLYPS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTRIC ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTRITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTROOESOPHAGEAL REFLUX DISEASE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GINGIVAL BLEEDING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATEMESIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATOCHEZIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMORRHOIDAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMORRHOIDS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ILEUS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "IMPAIRED GASTRIC EMPTYING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INGUINAL HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INGUINAL HERNIA, OBSTRUCTIVE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTESTINAL MASS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MELAENA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MOUTH HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NAUSEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 11, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ODYNOPHAGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OESOPHAGEAL HYPOMOTILITY", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PAROTID GLAND INFLAMMATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POOR DENTAL CONDITION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCTALGIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RECTAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SALIVARY GLAND DISORDER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TONGUE ULCERATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TOOTHACHE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 16, "numAffected": 14, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ADVERSE DRUG REACTION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 11, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "APPLICATION SITE PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ASTHENIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE DISCHARGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE HAEMORRHAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE INFLAMMATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHEST DISCOMFORT", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 15, "numAffected": 13, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CYST", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE BATTERY ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE CAPTURING ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE DISLOCATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE ELECTRICAL FINDING", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE INFUSION ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE LEAD DAMAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE MALFUNCTION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE STIMULATION ISSUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EXERCISE TOLERANCE DECREASED", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FATIGUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 14, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 9, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GENERALISED OEDEMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOTHERMIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INFUSION SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INJECTION SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INJECTION SITE HAEMORRHAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MALAISE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MEDICAL DEVICE COMPLICATION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUCOSAL HAEMORRHAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NON-CARDIAC CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 12, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OEDEMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OEDEMA PERIPHERAL", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 15, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 18, "numAffected": 13, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PELVIC MASS", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PYREXIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ULCER", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VESSEL PUNCTURE SITE HAEMATOMA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VESSEL PUNCTURE SITE HAEMORRHAGE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHOLECYSTITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHOLELITHIASIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEPATIC CIRRHOSIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEPATIC CONGESTION", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEPATOMEGALY", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERBILIRUBINAEMIA", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIVER DISORDER", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DRUG HYPERSENSITIVITY", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SEASONAL ALLERGY", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACUTE SINUSITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ASYMPTOMATIC BACTERIURIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CANDIDIASIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CLOSTRIDIAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CLOSTRIDIUM DIFFICILE COLITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CYSTITIS KLEBSIELLA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE RELATED INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIVERTICULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EAR INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ENDOCARDITIS ENTEROCOCCAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ENTEROCOCCAL BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ESCHERICHIA URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTROENTERITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HERPES ZOSTER", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INCISION SITE ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INFECTED BITES", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INFLUENZA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTERVERTEBRAL DISCITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LOCALISED INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NASOPHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ONYCHOMYCOSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ORAL CANDIDIASIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ORAL HERPES", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OTITIS MEDIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OTITIS MEDIA ACUTE", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PERITONITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 16, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 14, "numAffected": 13, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESPIRATORY TRACT INFECTION VIRAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RHINITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RHINOVIRUS INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SEPTIC SHOCK", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SINUSITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "STAPHYLOCOCCAL BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "STAPHYLOCOCCAL SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TOOTH INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "UPPER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 11, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 32, "numAffected": 23, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 19, "numAffected": 19, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URINARY TRACT INFECTION BACTERIAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URINARY TRACT INFECTION ENTEROCOCCAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "UROSEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VIRAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VIRAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VIRAL UPPER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "AGITATION POSTOPERATIVE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANAEMIA POSTOPERATIVE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANIMAL BITE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANKLE FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC PROCEDURE COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CATHETER SITE HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CERVICAL VERTEBRAL FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CONTUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CRANIOCEREBRAL INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EAR ABRASION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EAR INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ENDOTRACHEAL INTUBATION COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EXCORIATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FACE INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FALL", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 20, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 26, "numAffected": 21, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FEMUR FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FOOT FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FOREARM FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FROSTBITE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATURIA TRAUMATIC", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAND FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEAD INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HUMERUS FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "IN-STENT CORONARY ARTERY RESTENOSIS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTENTIONAL OVERDOSE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTERVERTEBRAL DISC INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "JAW FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "JOINT INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LACERATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 12, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 9, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIGAMENT SPRAIN", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIMB INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LUMBAR VERTEBRAL FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MULTIPLE FRACTURES", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCLE STRAIN", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OPEN WOUND", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PERIORBITAL HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST PROCEDURAL DIARRHOEA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST PROCEDURAL HAEMATURIA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST PROCEDURAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST PROCEDURAL HYPOTHYROIDISM", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST-TRAUMATIC PAIN", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL COMPLICATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL DIZZINESS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL HEADACHE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL HYPOTENSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROCEDURAL NAUSEA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RIB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKELETAL INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN WOUND", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SUBCUTANEOUS HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "THERMAL BURN", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TOXICITY TO VARIOUS AGENTS", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRAUMATIC HAEMATOMA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRAUMATIC HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRAUMATIC INTRACRANIAL HAEMORRHAGE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRAUMATIC LUNG INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "UPPER LIMB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URETHRAL INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URINARY RETENTION POSTOPERATIVE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VASCULAR GRAFT OCCLUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WRIST FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "AMYLASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD ALKALINE PHOSPHATASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD CREATINE PHOSPHOKINASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD CREATINE MB PHOSPHOKINASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 12, "numAffected": 9, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD CREATININE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 9, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD GLUCOSE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD POTASSIUM INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD PRESSURE DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD THYROID STIMULATING HORMONE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD UREA INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BRAIN NATRIURETIC PEPTIDE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARCINOEMBRYONIC ANTIGEN INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC ENZYMES INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC INDEX DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC OUTPUT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CLOSTRIDIUM TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DRUG LEVEL ABOVE THERAPEUTIC", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EJECTION FRACTION DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ELECTROCARDIOGRAM ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ELECTROCARDIOGRAM CHANGE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ELECTROCARDIOGRAM QT PROLONGED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FIBRIN D DIMER INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GAMMA-GLUTAMYLTRANSFERASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATOLOGY TEST ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMOGLOBIN DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEART RATE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HELICOBACTER TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEPATIC ENZYME INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTERNATIONAL NORMALISED RATIO INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIPASE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIVER FUNCTION TEST ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OCCULT BLOOD POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OXYGEN CONSUMPTION DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OXYGEN SATURATION DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PLATELET COUNT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PROTHROMBIN TIME PROLONGED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRANSAMINASES INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TROPONIN I INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TROPONIN INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 11, "numAffected": 11, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ULTRASOUND ABDOMEN NORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WEIGHT DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WEIGHT INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WHITE BLOOD CELL COUNT INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CACHEXIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DECREASED APPETITE", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEHYDRATION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 8, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSLIPIDAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FAILURE TO THRIVE", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FLUID OVERLOAD", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FLUID RETENTION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GOUT", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 11, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 16, "numAffected": 12, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERAMMONAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERCALCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERGLYCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERKALAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 17, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERNATRAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERPHOSPHATAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERVOLAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOCALCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOCHLORAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOGLYCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOKALAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 13, "numAffected": 12, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOMAGNESAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPONATRAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 16, "numAffected": 14, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOVOLAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LACTIC ACIDOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LACTOSE INTOLERANCE", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MALNUTRITION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "METABOLIC ALKALOSIS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TYPE 2 DIABETES MELLITUS", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VITAMIN D DEFICIENCY", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BACK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BURSITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FLANK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GOUTY ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "JOINT EFFUSION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIMB DISCOMFORT", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MOBILITY DECREASED", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCLE HAEMORRHAGE", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCLE SPASMS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCULAR WEAKNESS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCULOSKELETAL CHEST PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MYALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MYOSITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NECK MASS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NECK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OSTEOARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PAIN IN EXTREMITY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 11, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 10, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL OSTEODYSTROPHY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RHEUMATOID ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ROTATOR CUFF SYNDROME", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TENDONITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ADRENAL ADENOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "B-CELL LYMPHOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BASAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BOWEN'S DISEASE", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CANCER PAIN", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LUNG NEOPLASM", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MYELODYSPLASTIC SYNDROME", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PARAPROTEINAEMIA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SEBORRHOEIC KERATOSIS", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SQUAMOUS CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ALTERED STATE OF CONSCIOUSNESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "AMNESIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BALANCE DISORDER", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARPAL TUNNEL SYNDROME", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COGNITIVE DISORDER", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEMENTIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEMENTIA ALZHEIMER'S TYPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIABETIC NEUROPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 24, "numAffected": 18, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 18, "numAffected": 15, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIZZINESS POSTURAL", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSARTHRIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ESSENTIAL TREMOR", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GUILLAIN-BARRE SYNDROME", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOAESTHESIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LACUNAR INFARCTION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LOSS OF CONSCIOUSNESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LUMBAR RADICULOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "METABOLIC ENCEPHALOPATHY", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MIGRAINE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MYOCLONUS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PARAESTHESIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PARKINSON'S DISEASE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PARKINSONISM", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PARTIAL SEIZURES", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PHANTOM PAIN", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PRESYNCOPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 8, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESTLESS LEGS SYNDROME", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SCIATICA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SOMNOLENCE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SYNCOPE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 13, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRANSIENT ISCHAEMIC ATTACK", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TREMOR", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VASCULAR DEMENTIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANXIETY", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CONFUSIONAL STATE", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DELIRIUM", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEPRESSION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HALLUCINATION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INSOMNIA", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MAJOR DEPRESSION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MENTAL DISORDER", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MENTAL STATUS CHANGES", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PANIC ATTACK", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "STRESS", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLADDER SPASM", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CYSTITIS HAEMORRHAGIC", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEPHROLITHIASIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEPHROPATHY TOXIC", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PYURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL CYST", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL FAILURE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL FAILURE ACUTE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 30, "numAffected": 27, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 40, "numAffected": 29, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL FAILURE CHRONIC", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL IMPAIRMENT", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL INJURY", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL MASS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL TUBULAR NECROSIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URINARY RETENTION", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACQUIRED PHIMOSIS", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BENIGN PROSTATIC HYPERPLASIA", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BREAST INFLAMMATION", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BREAST MASS", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BREAST PAIN", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BREAST TENDERNESS", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GYNAECOMASTIA", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACUTE RESPIRATORY FAILURE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ASTHMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ATELECTASIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 14, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 11, "numAffected": 11, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPHONIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPNOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 23, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 39, "numAffected": 27, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPNOEA EXERTIONAL", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPNOEA PAROXYSMAL NOCTURNAL", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EMPHYSEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EPISTAXIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 13, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 11, "numAffected": 11, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMOPTYSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HICCUPS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERCAPNIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOXIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LUNG INFILTRATION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NASAL CONGESTION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OROPHARYNGEAL PAIN", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ORTHOPNOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PAINFUL RESPIRATION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PLEURAL EFFUSION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 19, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 13, "numAffected": 13, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PLEURITIC PAIN", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PNEUMONIA ASPIRATION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PNEUMONITIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PNEUMOTHORAX", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PRODUCTIVE COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY CONGESTION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY FIBROSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY HAEMORRHAGE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY HYPERTENSION", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY MASS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PULMONARY OEDEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESPIRATORY FAILURE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RHINITIS ALLERGIC", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WHEEZING", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACTINIC KERATOSIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ALOPECIA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ANGIOEDEMA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CUTIS LAXA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DECUBITUS ULCER", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DERMATITIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIABETIC FOOT", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DRUG ERUPTION", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ECCHYMOSIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ECZEMA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERHIDROSIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INCREASED TENDENCY TO BRUISE", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INGROWING NAIL", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PETECHIAE", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PRURITUS ALLERGIC", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RASH ERYTHEMATOUS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN HAEMORRHAGE", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN LESION", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN ULCER", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "STASIS DERMATITIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "URTICARIA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC PACEMAKER BATTERY REPLACEMENT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MEDICAL DEVICE BATTERY REPLACEMENT", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RENAL STONE REMOVAL", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ROUTINE HEALTH MAINTENANCE", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "AORTIC ANEURYSM", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "AORTIC STENOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ARTERIOVENOUS FISTULA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEEP VEIN THROMBOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FEMORAL ARTERY OCCLUSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMATOMA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HAEMORRHAGE", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 38, "numAffected": 35, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 33, "numAffected": 29, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "INTERMITTENT CLAUDICATION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ORTHOSTATIC HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PERIPHERAL ISCHAEMIA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SUBCLAVIAN ARTERY OCCLUSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "THROMBOPHLEBITIS SUPERFICIAL", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACUTE LEFT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHRONIC LEFT VENTRICULAR FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VENTRICULAR EXTRASYSTOLES", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEAFNESS BILATERAL", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EAR DISCOMFORT", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TYMPANIC MEMBRANE PERFORATION", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ADRENAL INSUFFICIENCY", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EUTHYROID SICK SYNDROME", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERPARATHYROIDISM SECONDARY", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHALAZION", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EPISCLERITIS", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "MYOPIA", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ABDOMINAL HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CHANGE OF BOWEL HABIT", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "COLONIC POLYP", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 13, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 13, "numAffected": 10, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DIVERTICULUM OESOPHAGEAL", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DYSPEPSIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FAECALOMA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FAECES DISCOLOURED", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FOOD POISONING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GASTRITIS EROSIVE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LARGE INTESTINAL ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LOWER GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OESOPHAGEAL ULCER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PANCREATIC CYST", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "DEVICE OCCLUSION", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EARLY SATIETY", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ACUTE TONSILLITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CYSTITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ESCHERICHIA INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LOWER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OTITIS EXTERNA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESPIRATORY SYNCYTIAL VIRUS INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "WOUND INFECTION BACTERIAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BACK INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CORNEAL ABRASION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "FACIAL BONES FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "JOINT DISLOCATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POST LUMBAR PUNCTURE SYNDROME", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ROAD TRAFFIC ACCIDENT", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD SODIUM ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CARDIAC PACEMAKER EVALUATION", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POSITRON EMISSION TOMOGRAM ABNORMAL", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SERUM FERRITIN DECREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SIMPLEX VIRUS TEST POSITIVE", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "IRON DEFICIENCY", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "VITAMIN B12 DEFICIENCY", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GROIN PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "OSTEOPOROSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "PLANTAR FASCIITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SPINAL DISORDER", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TORTICOLLIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "TRIGGER FINGER", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LIPOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEOPLASM", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SKIN PAPILLOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SQUAMOUS CELL CARCINOMA OF SKIN", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "CENTRAL NERVOUS SYSTEM LESION", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERSOMNIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEURALGIA", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "NEUROLOGICAL SYMPTOM", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "POLLAKIURIA", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "GENITAL LESION", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "IDIOPATHIC PULMONARY FIBROSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESPIRATORY DISTRESS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RESTRICTIVE PULMONARY DISEASE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "SLEEP APNOEA SYNDROME", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "BLOOD BLISTER", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ERYTHEMA MULTIFORME", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERKERATOSIS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RURITUS", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "RASH GENERALISED", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "EXTREMITY NECROSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "HYPERTENSIVE CRISIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LABILE HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LYMPHOEDEMA", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (15.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "ASD Closure Following Transseptal Catheterization", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "This falls under Additional procedures for the TVT registry Mitral module", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 162}]}, {"term": "Mitral Valve Reintervention", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Falls under additional procedure for the TVT Registry module", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 162}]}, {"term": "Unplanned Other Cardiac Surgery or Intervention", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 8, "numAffected": 7, "numAtRisk": 162}]}, {"term": "Other Device Related Event", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 162}]}, {"term": "Single Leaflet Device Attachment", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "Ischemic Stroke", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "Cardiac Readmission", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 20, "numAffected": 18, "numAtRisk": 162}]}, {"term": "Heart Failure Readmission", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 55, "numAffected": 38, "numAtRisk": 162}]}, {"term": "Non Cardiac Readmission", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 76, "numAffected": 43, "numAtRisk": 162}]}, {"term": "New Requirement for Dialysis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 162}]}, {"term": "Mitral Leaflet Injury", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "Bleeding at Access Site", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 162}]}, {"term": "GU Bleed", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "Life threatening Bleeding", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 162}]}, {"term": "Major Bleeding Event", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 162}]}, {"term": "Major Vascular Complications", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 162}]}, {"term": "Other Bleed", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 162}]}, {"term": "HAEMARTHROSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}, {"term": "LUNG ADENOCARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 302}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 312}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 162}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Sripad Bellary", "organization": "Abbott", "email": "sripad.bellary@abbott.com", "phone": "4088458114"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2016-10-12", "uploadDate": "2019-01-31T17:58", "filename": "Prot_000.pdf", "size": 5186540}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-06-04", "uploadDate": "2019-01-31T17:59", "filename": "SAP_001.pdf", "size": 443225}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000008944", "term": "Mitral Valve Insufficiency"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000006349", "term": "Heart Valve Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M11910", "name": "Mitral Valve Insufficiency", "asFound": "Mitral Regurgitation", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M9437", "name": "Heart Valve Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}